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ABSTRACT
There is growing concern about the potential cytotoxicity of nanoparticles. Exposure to
respirable ultrafine particles (2.5µM) can adversely affect human health and have been
implicated with episodes of increased respiratory diseases such as asthma and allergies.
Nanoparticles are of particular interest because of their ability to penetrate into the lung and
potentially elicit health effects triggering immune responses. Nanoparticles are structures and
devises with length scales in the 1 to 100-nanometer range. Black carbon (BC) nanoparticles
have been observed to be products of combustion, especially flame combustion and multiwalled carbon nanotubes (MWCNT) have been shown to be found in both indoor and outdoor
air. Furthermore, asbestos, which have been known to cause mesothelioma as well as lung
cancer, have been shown to be structurally identical to MWCNTs. The aims of these studies
were to examine the effects of carbon nanoparticles on murine macrophage function and
clearance mechanisms. Macrophages (MΦ) are immune cells that function as the first line of
defense against invading pathogens and are likely to be amongst the first cells affected by
nanoparticles. Our research focused on two manufactured nanoparticles, MWCNT and BC.
The two were tested against murine-derived MΦ in a chronic contact model. We hypothesized
that long-term chronic exposure to carbon nanoparticles would decrease MΦ ability to
effectively respond to immunological challenge. Production of nitric oxide (NO), tumor necrosis
factor alpha (TNFα), cell surface MΦ activation markers, reactive oxygen species formation
(ROS), and antigen processing and presentation were examined in response to
lipopolysaccharide (LPS) following a 144hr exposure to the particulates. Data demonstrated an
increase in TNFα, and NO production; a decrease in phagocytosis and antigen processing and
presentation; and a decrease in the expression levels of cell surface MΦ activation markers.
The data suggests that carbon nanoparticle exposure alters MΦ responses to LPS marked by
increased inflammation while potentially limiting clearance and ability to interact with effector Tcells. Thus, physiological exposure to carbon nanoparticles could potentially lead to ineffective
pulmonary immunity.
vi
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CHAPTER 1
INTRODUCTION
1.1

NANOPARTICLES
Nanotechnology is defined as research and technology development at the atomic,

molecular, and macromolecular scale, leading to the controlled manipulation and study of
structures and devices with length scales in the 1 to 100-nanometer (nm) range (McNeil,
2005).

Due to their small size and their particular physiochemical properties, research

indicates that toxicological profiles of nanoparticles may be significantly different from those of
larger particles composed of the same materials (Card et al. 2008).

Indeed, research

demonstrates that ultrafine or nanoparticles pose a much greater health risk than fine (2.5 µm)
and course (10 µm) particulate matter (PM) (Donaldson et al. 2001; Donaldson et al. 2004;
Machado et al. 2011; Murr et al. 2008; Nel et al. 2006; Oberdorster et al. 1994; Oberdorster,
2001; and Somasundaran et al. 2010).Moreover, nano-sized particles are able to disturb
biological systems at the cellular and subcellular levels (Kang et al. 2008).
Individuals are exposed on a daily basis to large numbers of ambient nanoparticles in
the form of air pollution (Donaldson et al. 2004) produced by industrial sources and naturally
occurring combustion processes such as forest fires and volcanic eruptions (Oberdorster et al.
2005). Additionally, exposure to engineered nanomaterials commonly used in sporting goods,
tires, stain-resistant clothing, sunscreens, cosmetics, and electronics occurs due to use normal
and wear-and-tear of the materials (Nel et al. 2006). For carbon nanoparticles such as black
carbon (BC) and multiwalled carbon nanotubes (MWCNT), the focus of our studies, they have
been observed to be products of combustion, especially flame combustion, and have been
identified in both indoor and outdoor air (Murr et al. 2005 and Murr, 2008). Additionally, BC is
1

commonly used in the production of tires as a strengthening agent making it abundant as tire
wear debris along roadways (Murr, 2008).

Furthermore, asbestos, known to cause

mesothelioma as well as lung cancer, has been shown to be structurally identical to the
engineered MWCNT (Figure 1) (Murr and Soto, 2004, Soto et al. 2004), while the commercial
BC is identical in shape to anthropogenic diesel soot aggregates such as wood and candle
particulate matter (Figure 2) (Garza et al. 2008).

1.2

NANOPARTICLE PROPERTIES AND TOXICITY
Nanomaterials dimensions range from 1 to 100 nm (McNeil 2005), as a result of their

small size and physical properties these can exhibit different characteristics when compared to
the same material in bulk form. Their small particle size makes them more potent than larger
2

particles because of their higher surface area and reactivity (Brauner et al. 2007). Due to their
size and shape, many nanoparticles can agglomerate and increase their net size, which can
potentially cause adverse health effects and affect the effective dose on the cellular system
(Oberdorster et al. 2005). Additionally, shape and agglomeration degree of particles in the
culture medium are important determinants for cytotoxic effects of carbon nanoparticles
(Hirano et al. 2010). Table 1 lists the physical properties of various nanoparticles, all made of
carbon atoms but with distinct shape; these nanoparticles are hydrophobic materials because
of their graphene structure and can easily agglomerate in aqueous solutions (Hirano et al.
2010).
Table 1. Physical properties of various carbon nanoparticles

Black carbon (BC) is a common nanoparticle composed of fine particles of more than
97% elemental carbon, characterized by spherule graphite sheets of carbon (Figure 2) (Sellers
et al. 2009). Its initial particle size is nano-size; however, van der Waals forces cause BC
particles to aggregate and eventually adhere to form stable agglomerates that can reach 1 to
over 100 µm in size. A different shaped carbon nanoparticle is carbon nanotubes (CNTs);
these are known for their cylinder/fiber like shape and strong structural properties. CNTs are
categorized as single-walled carbon nanotubes (SWCNTs) and multi-walled carbon nanotubes
(MWCNTs) (Figure 1). SWCNT consist of hollow cylinder like shape composed of one layer
thin sheet of graphene, while MWCNTs are made of various layers. It is now well established
that nanoparticles pose a much greater health risk than fine and course particulate matter
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(Murr, 2008) and that these nano-sized particles are able to disturb biological systems (Kang
et al. 2008).
The interaction of carbon nanoparticles with cellular system and toxicity is not well
understood. However, many toxicity studies suggest that there are many variables involved
such as nanoparticle shape, surface area, reactivity, and aggregation that can influence cell
toxicity (Nel et al. 2006). These properties could be influencing cell and organismal toxicity
through mechanisms such as oxidative stress and the generation of reactive oxygen species
(ROS). ROS can be produced directly when cells come into contact with the surface of carbon
nanoparticles, creating an oxidative stress reaction, which is a state of redox disequilibrium (Li
et al. 2008). Oxidative stress reaction can also be triggered by carbon nanoparticles that enter
the cells and are taken up by phagocytosis, which in turn induces oxidative stress by the
generation of free radicals.

Intracellular production of ROS is an important defense

mechanism to mediate toxicity, however, over production of ROS can overwhelm the cellular
antioxidant capacity. Thus, cells that have been stressed by exposure to foreign materials
such as carbon nanoparticles can cause over production of ROS that cannot be neutralized by
antioxidants and in turn leads to damage of DNA, proteins, and lipids by oxidation, as well as
inflammation, increased calcium concentrations, and cell death (Xia et al. 2006). Oxidative
stress caused by production of ROS can result in the release of various protein factors such as
cytokines, chemokines, and cell growth factors that can initiate reactions that would involve
immune and inflammatory cells and other reactive processes (Shatkin, 2008).

The latter

reaction is a result of inflammation, which is a protective response by the organism that is
designed to eliminate it of the foreign material that is causing the injury. The overwhelming
intracellular induction of ROS is mainly influenced by the surface and size of the carbon
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particles, since nano-sized particles have a large surface area to mass ratio it allows for a
greater induction of ROS than larger particles (Donaldson et al. 2003).
Carbon nanoparticles can also damage the mitochondria resulting in oxidative stress
and cell death (Li et al. 2003, Donaldson et al. 2003, and Simko et al. 2011). Deposits of BC in
the mitochondria can lead to the loss of mitochondrial membrane potential which releases
cytochrome c to the cytosol leading to damage of the inner mitochondrial membrane,
apoptosome formation, caspase 3 activation, poly ADP-ribose polymerase (PARP) cleavage,
and DNA fragmentation, ultimately resulting in apoptotic cell death (Xia et al. 2004 and
Hussain et al. 2010).

Carbon nanoparticles can also interact with lysosomal membranes

increasing lysosome membrane permeability, which releases lysosomal proteases that can
promote toxicity and cell death.

Since carbon nanoparticles are often internalized by

phagocytosis, they interact with the phagolysosome membrane resulting in the release of
lysosomal enzymes like cathepsin B into the cytosol to initiate apoptotic cell death. Studies
suggest that loss in lysosomal permeability contributes to apoptosis by factors such as
oxidative stress and inducing the release of tumor necrosis factor alpha (TNFα) (Thibodeau et
al. 2004).

Surface area and reactivity of the carbon nanoparticles appears to influence cell
morphology and cytotoxicity. For example SWCNTs and MWCNTs have a cylinder/fiber like
shape (Xia et al. 2006).

Cytotoxicity of SWCNTs and MWCNTs has been visualized by

examining cell morphology after exposure; results indicated disruption of plasma membrane
and presented with infiltration of the plasma membrane by MWCNT fibers (Hirano et al. 2010,
2008). These changes in cell morphology were attributed to hydrophobic contact between the
carbon nanoparticles and the cell membrane, thus making it possible for particles to perforate
the cell membrane, which is a unique property of insoluble particles (Geisser et al. 2005). The
5

cylinder/fiber-like shape could have increased the extent to which the particle associated with
the plasma membrane ultimately causing damage to the cell membrane and possibly loss of
cellular content and cell death.

1.3

IN VITRO AND IN VIVO CELL EFFECTS
There are various studies examining the effects of these materials both on in vitro and

in vivo models to elucidate the potential adverse health effects of nanoparticle exposure.
Nanoparticles have been shown to travel throughout the body, deposit in main organs,
penetrate cell membranes, lodge in mitochondria, and induce toxic responses (Nel et al. 2006).
Because of their nano-size these materials have the ability to redistribute from their site of
deposition and travel to various locations in the organism (Donaldson et al. 2004).
SWCNT and MWCNT are structurally identical to asbestos fibers, which have raised
concerns about the durability of these particles inside the organism after being inhaled.
Consequently, CNTs could potentially cause asbestos-like injuries, such as pulmonary fibrosis
and lung cancer.

As a result, many examinations with these carbon nanoparticles have

focused on toxicity in the pulmonary system.

Mice inhalation studies with SWCNT

demonstrated lung injury, inflammation, and granuloma formations (Warheit et al. 2004)
likewise, results in mice exposed to MWCNT also indicated pulmonary fibrosis, granuloma
formation, and inflammatory responses (Muller et al. 2005). The observed granulomas were
associated with large CNT aggregates in the lung while pulmonary fibrosis was correlated with
dispersed CNTs indicating a difference between aggregated and dispersed carbon
nanoparticles. The data suggested that chronic inhalation of carbon nanoparticles is difficult to
clear by phagocytic cells such as macrophages due to the constant overload in the animal’s
respiratory system. Long-term inhalation assessments of carbon nanoparticles have exhibited
6

an increase in systemic inflammation by production of pro-inflammatory cytokines and an
increase in granulomatus inflammation in the lung and draining lymph nodes (Lam et al. 2004).
Moreover, inhaled BC particles have been shown to produce inflammatory cytokines and
cytotoxic cellular responses in response to oxidative stress causing lung injury as well as low
clearance of these particles from the airways, therefore respiratory exposure to BC might
influence the exacerbation and development of inflammatory conditions of the airways such as
chronic obstructive pulmonary disease (COPD).
Animal studies have shown that particle size is critical to the ability of inhaled carbon
nanoparticles translocation.

Investigations have shown translocation of nano-size carbon

particles from the alveolar region to the circulatory system followed by distribution throughout
the body, including the vasculature, heart, liver, spleen, and bone marrow (Geiser and
Kreyling, 2010, Kreyling et al. 2009, Nemmar et al. 2002, and Peters et al. 2006). However,
only a low percentage of the carbon nanoparticles were able to translocate from the alveolar
region to the circulatory system, indicating a low clearance mechanism for these nano-sized
particles from their initial deposition site. Nevertheless, nanoparticle access to different tissues
in the body could explain why exposure to ambient carbon nanoparticles has been associated
with health conditions such as pulmonary and cardiovascular diseases (Li et al. 2007).
Retention of carbon nanoparticles on organisms’ tissues due to reduced clearance
mechanisms can potentially interfere with effective immune responses. Lastly, large surface
area of carbon nanoparticles appears to be the most important determinant of toxicity in cell
and animal models mainly by uncontrolled ROS formation and oxidative stress.

7

1.4

MACROPHAGES
Nanoparticles are of particular interest because of their ability to penetrate deep into the

lung and potentially elicit health effects triggering immune responses (Wegesseer et al. 2008),
potentially through interactions with macrophages (MΦs). These phagocytes are specialized
white blood cells that are considered sentinels and effectors of innate immunity (Reiner, 2009).
Before differentiating into MΦs these cells are monocytes that originate from hematopoietic
stem cell (HSC) derived progenitors with myeloid-restricted differentiation potential
(Geissmann et al. 2010). Monocytes are produced in the bone marrow and released into the
blood where they circulate or reside in the spleen before migrating into tissues during infection.
For monocytes to migrate they use chemokine receptors CCR2 (also known as monocyte
chemo-attractant protein 1 - MCP-1) and adhesion molecules such as cluster of differentiation
54 (CD54), which allow the monocytes to adhere to tissues where they differentiate to MΦs or
DCs (Robbins and Swirski, 2010). For differentiation to occur, monocytes need specific growth
or differentiation cytokines such as Macrophage Colony-Stimulating Factor (M-CSF), cytokine
responsible for differentiation of monocytes into MΦs (Geissmann et al. 2010).
1.5

MACROPHAGE ACTIVATION
MΦs, the mature form of monocytes, are large (approximately 25 to 50 µm in diameter)

antigen presenting cells (APCs) that are an important component of innate immune response
to infection (Russell and Gordon, 2009). They are ubiquitous, located in many tissues such as
the skin, lungs, spleen, lymph nodes, and liver, where they serve as filters for trapping foreign
microbes. MΦ migrate into tissues in the steady-state or in response to inflammation where
they are involved in tissue homeostasis by eliminating cellular debris generated during tissue
repair. They are also involved in wound healing, removing cellular material from cells that
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have gone through apoptosis and/or necrosis via the recognition of exposed intracellular
membrane components.
MΦs respond to signals produced by innate immune cells and from APCs that arise
after injury or infection (Mosser and Edwards, 2008).

Upon recognition of a microbe or

infected cell, MΦs engulf the foreign material to initiate MΦ-specific clearance mechanisms
and to further process the ingested material as antigenic molecules for other immune cells to
respond to (Palomaki et al. 2010). Thus, MΦs play a central role in host defense to pathogens
by mediating important functions such as phagocytosis, removal by lysosomal degradation,
production of cytokines and chemokines, and as APCs to primed T cells. The latter occurs
through the major histocompatibility complex class II molecules (MHCII) by enzymatic
degradation of antigens and binding of protein fragments (peptides) to MHC molecules to the
cell surface for presentation (Russell and Gordon, 2009). Once peptide has been presented at
the cell surface by MHCII binding to the T cell receptor (TCR) an additional signal is required
such as stimulation by cytokines or through co-stimulatory molecules, such as CD80 and
CD86 which in turn interact with CD28, the receptor protein on the surface of T cells, thus
activating T cells to elicit a immune response to in turn activate innate immune cells to
eliminate foreign pathogens.
For MΦs to perform most of their primary functions during an immune response, these
cells must be activated (Xaus et al. 2000). MΦs are activated by toll-like receptor (TLR)
ligands such lipopolysaccharide (LPS), which is a bacterial product of a complex glycolipid
endotoxin that is a major component of gram-negative bacterial wall (Stout and Suttles, 1995)
or by cytokines secreted by T cells such as interferon-γ (IFN-γ). When activated, MΦs can act
as scavenger cells, participate in tissue repair, kill microbial pathogens including bacteria,
9

viruses, fungi, protozoa, and parasites; activated MΦs also secrete inflammatory cytokines,
process antigens and present them to T cells. (Xaus et al. 2000). Furthermore, when MΦs
become activated they up-regulate expression of cell surface molecules such as CD80, CD86,
and major histocompatibility complex (MHC) class 2 antigen (MHCII), nitric oxide (NO)
formation, produce pro-inflammatory cytokines such as tumor necrosis factor alpha (TNFα),
interleukin molecules (IL) IL-6, and IL-12, and chemokines (CC and CXC) (He et al. 2008 and
Javala et al. 2008). Additionally, cytokine secretion by MΦs can be triggered by microbial
products, interaction with Type I Helper T cells (Th1), or by soluble factors including other
cytokines. All of such activities aid MΦs in their innate and adaptive immune functions.
Phagocytosis of microbes by MΦs initiates the innate immune response that, in turn,
finalizes and maintains the activation of the adaptive immune response at the target site of
infection (Russell and Gordon, 2009). When foreign material is encountered by MΦs they
become activated, in this state they increase phagocytosis a process that involves
internalization of the pathogen by the plasma membrane that leads to fusion in a membrane
bound vacuole, the phagosome. The phagosome that contains the pathogen then fuses with a
lysosome (phagolysosome), followed by digestion of the pathogen by the lysosomal enzymes,
resulting in the degradation of the ingested pathogen (Russell and Gordon, 2009).

This

process can lead to antigen presentation and removal of invading pathogens by presentation
of an antigen from the pathogen on the cell surface. Mosser and Edwards (2008) describe that
MΦs express low levels of MHC II, but the expression can be up-regulated by LPS as well as
IFN- γ, allowing the MΦs to present antigens to primed T cells. Primed T cells enter the site of
infection due to signals being provided by infected cells and by the MΦs. The MΦ – T cell
peptide-specific interaction causes production of IL-12 by the MΦ to expand Th1 cell
10

population, which results in IFN- γ production by the T cells to activate MΦs and increase its
activity to eliminate microbes, underscoring the critical role of MΦs in regulation of the adaptive
immune system (Palomaki et al. 2010).
Studies suggest that MΦ phagocytic ability is reduced by the presence of fine and
course particulate matter hence affecting the clearance of the particles from the alveolar region
of the lung (Barlow et al. 2008). However, not much is known about the interaction of MΦ and
carbon nanoparticles in the presence of a pulmonary infection and the ability of these APCs to
produce a response to a bacterial infection.

1.6

DISSERTATION GOALS
The response of MΦs to carbon nanoparticulate materials is poorly understood. This

research is significant because many biological aspects of specific constituents of
nanoparticulate matter still remains unclear and requires further evaluation.

Exposure to

respirable ultrafine or nanoparticulate matter (PM) designated PM0.1, indicative of particulates
smaller than 0.1µm in diameter, can adversely affect human health and have been implicated
with episodes of increased respiratory diseases such as asthma and allergies (Bush, 2000).
Nanoparticles are of particular interest because of their ability to penetrate into the lung and
potentially elicit health effects triggering immune responses (Wegesseer et al. 2008). There is
a lack of research examining contemporary carbon nanoparticles and their potential ability to
aggravate pulmonary immunity as well as affect our ability to fight future infections. Thus,
physiological exposure to carbon nanoparticles could potentially lead to ineffective pulmonary
immunity.

Thus, the goal of these studies is to assess the chronic effects of carbon

nanoparticles on murine MΦ function and clearance mechanisms. The central hypothesis is
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that MΦ exposed to carbon nanoparticles would not suffer compromised immediate immune
functions. However, long-term exposure to the nanomaterial would alter the MΦ’s ability to
respond appropriately to future microbial stimuli resulting in compromised immunity. Our data
demonstrates that chronic “pre-exposure” to carbon nanoparticles, black carbon specifically,
impedes MΦ response to a microbial stimulus. Thus, physiological exposure to carbon
nanoparticles could potentially lead to ineffective pulmonary immunity. The significance for the
studies described in this dissertation is that the identification of key cellular responses to
engineered carbon nanoparticles can establish a strong framework in the study of how the
environment and anthropogenic activities influence and alter MΦ function, which may
ultimately interfere with effective pulmonary immune responses capable of increasing the
development and progression of human diseases like chronic obstructive pulmonary disease
(COPD).
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CHAPTER 2
IN VITRO CYTOTOXIC EFFECTS OF CARBON NANOPARTICLES,
MICRON-METALS, AND NANO-METALS
2.1

INTRODUCTION
Research demonstrates that ultrafine or nanoparticles of different compositions pose a

much greater health risk than fine and course particulate matter (PM) (Buzea et al. 2007;
Donaldson et al. 2001; Donaldson et al. 2004; Machado et al. 2011; Murr et al. 2008; Nel et al.
2006; Oberdorster et al. 1994; Oberdorster, 2001; and Somasundaran et al. 2010) and that
these nano-sized particles are able to disturb biological systems at the cellular and subcellular
levels (Kang et al. 2008). In the present study, we examined in vitro toxicity of two distinct
engineered carbon nanoparticles on a murine macrophage (MΦ) cell line (RAW264.7). In
addition, ballistic aerosols composed of ultrafine (nano-sized) and fine (micron-sized) metal
particulates were tested for toxicity using a human lung epithelial cell line (A549). The studies
detailed herein were conducted in order to evaluate in a controlled and simple experimental
model, the potential cytotoxic effects of anthropogenic micron and nanoparticles on eukaryotic
cells.
Nanoparticles are structures and devises with length scales in the 1 to 100-nanometer
range and micron-sized particles describes fine particles that are less than or equal to 2.5micrometer in diameter (McNeil, 2005).

Black carbon (BC) nanoparticles are products of

combustion, especially flame combustion; multi-walled carbon nanotubes (MWCNT) have
been shown to be found in both indoor and outdoor air (Murr et al. 2005 and Murr, 2008). Of
note is that asbestos, which has been known to cause mesothelioma as well as lung cancer, is
13

structurally identical to MWCNTs (Murr et al. 2005).

Ballistic aerosols are generated by

military gun firing at rod projectiles. These particles are released by kinetic energy penetrator
rods of tungsten heavy alloys perforating steel target plates. Machado et al. (2010) collected
ballistic aerosol debris after tungsten heavy alloy penetrators were fired into steel plates that
were encapsulated in a steel containment vessel inside military armored vehicles. The study
found that the generated ballistic aerosol debris was mostly composed of nanoparticulates with
an average particle size of ~10 nm. Additionally, particle characterization by SEM and TEM
revealed that they consist of various metal nanoparticles (iron [Fe], tungsten [W], nickel [Ni],
and cobalt [Co]). Moreover, previous work in our laboratory in collaboration with Machado et
al. (2010) performed cytotoxicity assays with filter collected ballistic particles on A549 cells
using a direct contact cell culture method previously described by Garza et al. (2008) and Soto
et al. (2008b). Results demonstrated that direct exposure of A549 cells to single stage filter
samples was highly cytotoxic. In addition, previous experiments in our laboratory have shown
that a wide range of anthropogenic carbon and metal particles are cytotoxic to eukaryotic cells
(Garza, et al., 2008).

Together, our work suggests that inhalation exposure to metal

nanoparticles could be a potential hazard to human health.

Thus, we decided to further

examine this phenomena using engineered MWCNT’s, BC carbon nanoparticles as well as
various metal nano-sized and micron-sized particles as mimics for anthropogenic carbon and
metal nanoparticles found in the environment (Murr, 2008). Cytotoxicity was measured as a
function of cell viability and inflammatory cytokine production.
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2.2

MATERIALS AND METHODS
Nano-sized and micron-sized metal particles.

As described by Machado et al.

(2011) various commercially available nano-sized and micron-sized metal particles (Fe, W, Ni,
and Co) were purchased to simulate the elemental compositions of two tungsten heavy alloy
rods. The tungsten alloy rods had been previously characterized (Machado et al. 2010) and
found to contain 91% W, 5.6% Ni, 1.4% iron Fe, and 92% W, 6% Ni, and 2% Co. The
commercially available nano-sized and micron-sized metal particles were further characterized
by Machado et al. (2011) using a Hitachi S-4800 field-emission scanning electron microscope
(FESEM) fitted with an EDAX energy- dispersive spectrometry system. Additionally, TEM
equipped with a digital camera allowed direct magnifications of over 10,000,000X of the metal
particles. These were placed onto a SiO/Formvarcoated Cu (200 mesh) TEM grid (3 mm
diameter) and then sandwiched with another grid on top to contain the powder. Both nanosized and micron-sized metal particles were suspended at 3 mg/mL in dimethyl sulfoxide
(DMSO) (Sigma-Aldrich, St. Louis, MO) to create a stock solution. The solutions were further
diluted in cell media for the assays and were re-suspended prior to administration to the cells
using a vortex (1 min) to minimize metal particle agglomeration.
Carbon nanomaterials. Black carbon (BC) (Vulcan XC-72) from Cabot Corporation
(Billerica, MA) and multi-walled carbon nanotubes (MWCNT) powder purchased from Rosseter
Holdings, Inc (Limassol, Cyprus) were used for our experiments. Both carbon nanoparticles
have been characterized by Soto et al. (2005) by transmission electron microscopy (TEM)
using a Hitachi H-8000 analytical TEM operated at 200kV accelerating potential and fitted with
a goniometer-tilt stage, and a noran energy-dispersive (X-Ray) spectrometer (EDS). Carbon
nanoparticles were suspended at 5 mg/mL in DMSO (Sigma-Aldrich, St. Louis, MO) to create a
stock solution. The solutions were further diluted in cell media for the experimental assays and
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were re-suspended prior to administration to the cells using a vortex (1 min) to minimize
carbon nanoparticle agglomeration.
Cell lines. Human epithelial lung cell line (A549) and murine MΦ RAW264.7 (TIB-71)
were obtained from the American Type Culture Collection (ATCC, Manassas, VA). A549 cells
were cultured at 37ºC and 5% CO2 in F-12 Ham’s media, supplemented with 10% fetal bovine
serum (FBS) and penicillin-streptomycin (5%) from Fisher Scientific (Pittsburg, PA). RAW264.7
cells were cultured at 37ºC and 5% CO2 in Dulbecco’s Modified Eagle Media (DMEM)
supplemented with 10% fetal bovine serum (FBS), 5% penicillin-streptomycin, 5% sodium
pyruvate, and 5% glutaMAX from Fisher Scientific (Pittsburg, PA).
Viability assays. Viability of A549 cells after exposure to nano-sized or micron-sized
metals

was

assessed

by

a

tetrazolium

compound,

3-(4,5-dimethylthiazol-2-yl)-5-(3-

carboxymethoxyphenyl)-2- (4-sulfophenyl)-2H-tetrazolium, inner salt (MTS) assay, which is a
colorimetric method for determining the number of viable cells as a function of mitochondrial
redox potential (CellTiter 96 Aqueous One Solution Reagent, Promega Corporation, Madison,
WI). In brief, 1 x 105 cells per well were seeded in a 12-well plate (Fisher Scientific, Pittsburg,
PA) and allowed to attach to the surface for 24 h prior to metal particle exposure.
Subsequently, metal particles (nano-sized or micron-sized at 10 µg/mL, 5 µg/mL, and 2.5
µg/mL) and DMSO (vehicle control) were added for 48 hr. Following exposure, the cells were
trypsinized, centrifuged, and re-suspended in 1 mL of complete DMEM; 100 µl of cell
suspension was transferred to a 96-well plate (Fisher Scientific, Pittsburg, PA) in replicates of
five and 20 µl of MTS solution was added to each well. The plate was then placed in the
incubator at 37ºC and 5% CO2 for 2 hr. Relative viability was measured at 490 nm using a
microplate spectrophotometer (VersaMax Microplate Reader, Molecular Devices).
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Carbon nanoparticle dose response.

We performed a carbon nanoparticle dose

response assay, which allowed us to identify the concentration at which the materials exhibit a
median lethal concentration (LC50). The viability of RAW264.7 cells after exposure to BC and
MWCNT was assessed by CellTiter Glo luminescent assay as described by the manufacturer
(Promega Corporation, Madison, WI). The CellTiter Glo assay is a luminescent method for
distinguishing the number of viable cells in culture based on quantification of adenosine-5’triphosphate (ATP), which signals the presence of metabolically active cells.

Carbon

nanoparticles (MWCNT and BC) were tested in a dose dependent concentration ranging from
10 µg/mL to 100 µg/mL.

In brief, 3.5 X 105 cells per well were seeded in 6-well plates

(Midwest Scientific, St. Louis, MO) and allowed to attach to the surface for 24 h prior to carbon
nanoparticle exposure. Subsequently, carbon nanoparticles (MWCNT’s and BC) and DMSO
(vehicle control) were added for 48 hr. Following exposure, the cells were harvested,
centrifuged, and re-suspended in 1 mL of complete DMEM; 100 µl of cell suspension was
transferred to opaque-walled 96-well plate (VWR, Radnor, PA) in replicates of four. An equal
volume of the Cell Titer Glo substrate was then added to each well. The plate was then placed
on a shaker for two minutes to induce cell lysis. Next, viability was measured as a function of
relative light units (RLU) using a microplate luminometer (Luminoskan Ascent, Thermo
Scientific).
Lipopolysaccharide (LPS) dose response. LPS from E.coli was obtained from VWR
(Radnor, PA) and used in a dose response assay to identify the optimal LPS concentration at
which RAW264.7 MΦ cells become activated. We tested LPS-treated RAW264.7 cell viability
by MTS assay and pro-inflammatory cytokine production (tumor necrosis factor alpha - TNFα)
by enzyme-linked immunosorbent assay (ELISA).

In brief, 3.5 x 105 cells per well were

seeded in 6-well plates (Midwest Scientific, St. Louis, MO) and allowed to attach to the
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surface. LPS stimulation was tested in a dose dependent concentration ranging from 0.1
µg/mL to 8 µg/mL. 24 hrs post-stimulation with LPS, culture supernatants were collected and
stored -20 C for later analysis of cytokine detection by ELISA. To test for viability, the cells
were harvested, centrifuged, and re-suspended in 1 mL of complete DMEM; 100 µl of cell
suspension was transferred to a 96-well plate (Fisher Scientific, Pittsburg, PA) in replicates of
five and 20 µl of MTS solution was added to each well. The plate was then placed in the
incubator at 37ºC and 5% CO2 for 2 hr. Next, viability was measured at 490 nm using a
microplate spectrophotometer (VersaMax Microplate Reader, Molecular Devices).
Cytokine assay. Pro-inflammatory cytokine production (tumor necrosis factor alpha TNFα) by RAW267.4 cells was measured using commercially available enzyme-linked
immunosorbent assay (ELISA) kits (BioLegend, San Diego, CA). The ELISA analysis was
performed according to manufacturer’s instructions.

Briefly, microtiter ELISA plates were

coated with anti-TNFα capture antibody overnight at 4ºC. The plates were then blocked at
room temperature with 3% bovine serum albumin in PBS. Cell culture supernatants from
treated MΦ were added to the plates. Following binding of cytokines to the capture antibodies,
the plates were incubated with biotin-conjugated anti-TNFα antibody, followed by streptavidinHRP (Biosource/Life Technologies, Grand Island, NY). The chromogenic substrate 3,3’5,5’tetramethylbenzidine (TMB) (Genscript, Piscataway, NJ) was utilized for color development
and absorbance was measured by microplate spectrophotometer (VersaMax Microplate
Reader, Molecular Devices).

Cytokine concentrations were calculated against murine

recombinant cytokines (BD Pharmingen, San Jose, CA).
Toxicity analysis in RAW264.7 cells. The viability of RAW264.7 cells after exposure to
BC and MWCNT was assessed by CellTiter Glo luminescent assay as described by the
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manufacturer (Promega Corporation, Madison, WI). The CellTiter Glo assay is a luminescent
method for distinguishing the number of viable cells in culture based on quantification of
adenosine-5’-triphosphate (ATP), which signals the presence of metabolically active cells. In
brief, 4 x 105 cells per well were seeded in 6-well plates (Midwest Scientific, St. Louis, MO )
and allowed to attach the surface for 24 h prior to carbon nanoparticle exposure.
Subsequently, carbon nanoparticles (MWCNT’s and BC at 30 µg/mL) and DMSO (vehicle
control) were added for 48 hr. Following exposure, the cells were harvested, centrifuged, and
re-suspended in 1 mL of complete DMEM; 100 µl of cell suspension was transferred to
opaque-walled 96-well plate (VWR, Radnor, PA) in replicates of five. An equal volume of the
Cell Titer Glo substrate was then added to each well. The plate was then placed on a shaker
for two minutes to induce cell lysis. Next, viability was measured as a function of relative light
units (RLU) using a microplate luminometer (Luminoskan Ascent, Thermo Scientific).
Toxicity analysis in RAW264.7 cells. Two methods were used to measure cell viability
and cytotoxicity of RAW264.7 cells after chronic “exposure” and “pre-exposure” to BC and
MWCNT. The first one to be used was a trypan blue viability assay; this method determines
cell viability based on cell membrane integrity. The cells were divided into the following
treatments: media (negative control), media stimulated (lipopolysaccharide, LPS 100 ng/mL –
positive control), MWCNT treated (30 µg/mL), BC treated (30 µg/mL), and dimethylsulfoxide
(DMSO) treated (vehicle control). On day 0, MΦ were plated into 6-well plates. The following
day (day 1), carbon nanoparticles (BC and MWCNT) and vehicle control (DMSO) were added
to the indicated wells. On day 4, the cells were washed with phosphate buffered saline (PBS)
and treatments were refreshed. Subsequently, on day 6, the cells were washed with PBS and
treatments were refreshed. Additionally on day 6, but only for the “pre-exposure” set of plates,
lipopolysacharide (LPS -100 ng/mL) stimulus was added to all treatments except to the
19

negative control. The administration of LPS functioned as a mimic for a bacterial infection
following a chronic exposure to the carbon nanoparticles.

Alternatively, on day 6 for the

“exposure” model, LPS (100 ng/mL) stimulus was only added to the positive control. This
series of plates assessed the impact of chronic exposure, in the absence of infection, on the
MΦ. Twenty-four hrs later, on day 7, the function of the MΦs were assessed for both “preexposure” and “exposure” models. Following carbon nanoparticle exposure, the cells were
gently removed from the plate surface by scrapping, harvested, centrifuged, and re-suspended
at 1 mL of complete DMEM. Next, 10 µl of cell suspension was mixed with 10 µl of 0.4%
trypan blue followed by cell counting in the Cellometer Auto T4 Instrument (Nexcelom
Bioscience, Lawrence, MA). The second method for testing cell viability and cytotoxicity was
by the LIVE/DEAD Viability/Cytotoxicity Kit for mammalian cell (Life Technologies, Grand
Island, NY). The LIVE/DEAD assay is a two color fluorescent assay that identifies live versus
dead cells on the basis of membrane integrity and esterase activity. Membrane-permeant
calcein AM is cleaved by esterase activity in live cells to yield cytoplasmic green fluorescence,
and membrane-impermeant ethidium homodimer-1 labels nucleic acids of membranecompromised cells with red fluorescent (Life Technologies, Grand Island, NY).

Following

carbon nanoparticle chronic “exposure” and “pre-exposure”, the cells were gently removed
from the plate surface by scrapping, harvested, centrifuged, and re-suspended at 1 mL
suspension of cells with 1 x 106 cells/mL in FACS buffer (1X phosphate buffered saline (PBS),
2% FCS, and 0.1% sodium azide). Next, we added 2 µl of 50 µM calcein AM working solution
to 4 µl of the 2 mM ethidium homodimer-1 stock to each sample and incubate cells for 20 min
at room temperature. Cells were then analyzed via flow cytometry (Beckman Coulter FC500
System).
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Statistical Analysis. The data is presented as the mean ± SEM of replicate wells and
is one of three representative experiments. The differences among treatment groups was
evaluated using one-way ANOVA with a post-hoc Tukey test with a significance level of
p<0.05. (GraphPad Prism software v. 5.00, San Diego, CA).
2.3

RESULTS

Nano-sized (nm) metals particles are more cytotoxic to A549 cells than micron-sized
(µm) metals particles.
We investigated the effects of size-dependent particle toxicity on A549 cells using four
different commercially available micron and nano-sized particles (Fe, W, Ni, and Co). The
particles used were representative of the elemental compositions of two tungsten heavy alloy
rods ballistic debris previously collected and characterized by Machado et al. (2010). A549
cells were exposed for 48 hrs to different concentrations (10 µg/mL, 5 µg/mL, and 2.5 µg/mL)
of both micron and nano-sized metal particles and assessed for viability by the MTS assay.
Results demonstrated that nano-sized metal particles at all concentrations (Figure 3 A, C, and
E) were more toxic to A549 cells than the micron-size particles (Figure 3 B, D, and F). The
results are consistent with studies that determined that smaller size particles, such as
nanoparticles seem to be more toxic than fine and course particles (Buzea et al. 2007;
Donaldson et al. 2001; Donaldson et al. 2004; Machado et al. 2011; Murr et al. 2008; Nel et al.
2006; Oberdorster et al. 1994; Oberdorster, 2001; and Somasundaran et al. 2010)
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Figure 3. Nano-sized (nm) metals are more cytotoxic to A549 cells than micron-sized (µm) metals. A549
cells were treated with nano-sized (nm) or micron-sized (µm) metal particles at a concentration of 10
µg/mL (A, B), 5 µg/mL (C, D), and 2.5 µg/mL (E, F). The cells were tested for viability as a function of
mitochondrial redox potential (MTS assay) 48 hrs post-treatment. Media was used as a negative
control and DMSO (equal volume as to treatments) as a vehicle control. This data is presented as the
mean ± SEM of duplicate wells and is one of three representative experiments. Notes: *P < 0.05; **P <
0.0015; ***P < 0.0001

BC is cytotoxic to RAW264.7 cells
To study the cytotoxicity effects of MWCNT and BC particles on MΦ and to determine
the concentration of the particles to use in the chronic experiments, a dose response viability
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assay to an acute exposure was first performed. MΦ were exposed for 48 hr to increasing
concentrations of carbon nanoparticles, MWCNT and BC (10 µg/mL to 100 µg/mL) and
assessed for viability by the CellTiter Glo assay.

The luminescent-based assay was

specifically selected to eliminate interference of the carbon materials with a colorimetric-based
assay. Results demonstrated that BC and MWCNT carbon nanoparticles are cytotoxic to the
MΦ in a dose dependent manner (Figure 4). Additionally, the cytotoxic assessment
demonstrated that BC alters MΦ cell viability with an LC50 of 30 µg/mL. The results also
demonstrated that BC is markedly more cytotoxic than MWCNT. Previous MWCNTs
anthropogenic collection studies (Soto et al. 2005) indicate that this carbon nanoparticle is
found in low concentrations in the environment, which makes it difficult to collect in sufficient
quantities to perform adequate assays. Thus, rather than use MWCNT at its LC50, which
would have been significantly high and likely not realistic to environmental exposure doses, we
chose to keep MWCNT at the same concentration as the BC LC50.
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Figure 4. MWCNT and BC are cytotoxic to RAW264.7 MФ. MФ were treated with increasing
concentrations of the indicated carbon nanoparticles and were assessed for viability using a
luminescent assay 48hrs post-treatment. This data is presented as the mean ± SEM of triplicate wells
and is one of three representative experiments.

Increasing concentrations of LPS do not affect RAW264.7 MΦ cell viability but reveals a
dose dependent production of TNFα.
A dose response assay was performed to identify the optimal LPS concentration at
which RAW264.7 MΦ cells become activated. This assay was necessary to identify the LPS
concentration to be used as a positive control for MΦ activation in all in vitro experiments. MΦ
were exposed for 24 hr to increasing concentrations of (0.1 µg/mL – 8 µg/mL) of LPS, and
assessed for viability by MTS assay. Our results demonstrated no loss in viability (Figure 5).
Additionally, the results for the cytokine detection ELISA revealed a dose dependent
production of TNFα by the LPS treated RAW264.7 MΦ (Figure 6). Thus, we chose 0.1 µg/mL
of LPS since it exerted no loss in viability and induced an exponential increase in proinflammatory cytokine production.
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Figure 5. Increasing concentrations of LPS do not affect RAW264.7 MФ cell viability. MФ were treated
with increasing concentrations of LPS and were assessed for viability by MTS assay 24hrs posttreatment. This data is presented as the mean ± SEM of duplicate wells and is one of three
representative experiments.

Figure 6. Increasing concentrations of LPS revealed a dose dependent production in TNFα by RAW264.7
MФ. MФ were treated with increasing concentrations of LPS and were assessed for TNFα production
by ELISA. This data is presented as the mean ± SEM of duplicate wells and is one of three
representative experiments.
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Chronic “exposure” and “pre-exposure” to BC is cytotoxic to RAW264.7 cells.
Cytotoxicity assays were performed to determine the long term effects of carbon
nanoparticles treatment on MΦ cells. After a 7 day chronic “exposure” and “pre-exposure” to
MWCNT and BC, we assessed cellular cytotoxicity by the CellTiter Glo assay. The CellTiter
Glo assay is a luminescent method for distinguishing the number of viable cells in culture
based on quantification of adenosine-5’-triphosphate (ATP), which signals the presence of
metabolically active cells. As shown in Figure 7A and 7B, results from the CellTiter Glo assay
demonstrate that both “exposure” and “pre-exposure” to BC decreases cell viability. However,
no statistical difference was observed for any other measurement.

Figure 7. Chronic “pre-exposure” and “exposure” to BC is cytotoxic to RAW264.7 cells. MФ were treated
with MWCNT or BC and “Pre-Exposure” (A) samples were activated with 100ng/mL of LPS.
Treatments were tested for cytotoxicity by CellTiter Glo assay 7 days post-treatment. Untreated-cells
(media) and vehicle-treated cells (DMSO) were used as controls. This data is presented as the mean ±
SEM of quadruplicate wells and is one of three representative experiments.
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2.4

DISCUSSION
This study indicated that nanoparticles are markedly more cytotoxic to cells than

micron-sized particles of the same composition. A549 cells showed decreased cell viability
when exposed to nano-sized metal particles, whereas, micron-size particles were not as toxic.
Similarly, other in vitro studies have observed increased cytotoxic response with nanomaterials
when compared to micron-sized or larger particles (Buzea et al. 2007, Donaldson et al. 2004,
Machado et al. 2011, Murr et al. 2008; Nel et al. 2006, Somasundaran et al. 2010, Soto et al.
2008a). Additionally, in vivo rat studies using TiO2 or BC particles with two sizes show that the
smaller particles (nanomaterial) exhibit greater inflammation and systemic effects when
compared to larger size particles (Donaldson et al. 2001, Renwick et al. 2004, Oberdorster et
al. 1994), and when inhaled can be found in lung tissues (Oberdorster, 2001). As described by
Machado et al. (2010) there are several well characterized studies that examined the effects of
Co, Ni, W, and Fe exposure and demonstrated that these metal particles are cytotoxic and
exacerbate pulmonary fibrosis, asthma, pulmonary edemas, and pneumonia. This is likely due
to their small particle size, which makes them more potent than larger particles because of
their higher surface area and reactivity (Brauner et al. 2007). Due to their size and shape,
many nanoparticles can agglomerate and increase their net size, which can potentially cause
adverse health effects and affect the effective dose on the cellular system (Oberdorster et al.
2005). This study is of particular importance to human health because the nano-sized and
micron-sized particles analyzed were from ballistic aerosol debris collected inside military
armored vehicles (Machado et al. 2010).
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The present study also examined two distinct carbon nanoparticles (BC and MWCNT)
that are commonly found in our environment in the form of air pollutants. These particles are
produced by combustion processes, especially flame combustion, and have been identified in
both indoor and outdoor air (Oberdorster et al. 2005, Murr et al. 2005, Murr et al. 2006, and
Murr, 2008). In order to investigate potential cell toxicity of carbon nanoparticles, cell viability
was examined using commercially available particles as mimics for the anthropogenic
materials. Cytotoxic assessments demonstrated that BC alters MΦ cell viability with an LC50
of 30 µg/mL and indicated that BC is more toxic than MWCNT. Our laboratory has previously
shown that there is a decrease in cell viability in RAW264.7 and A549 cells treated for 48 hrs
with BC or MWCNT (Murr et al. 2006, Soto et al. 2005). Additionally, two chronic six-day
exposure models were also established, “pre-exposure” and “exposure”. The “pre-exposure”
model was formulated to investigate the potential ability of carbon nanoparticles to alter MΦ
responses to future microbial insults; the “exposure” model was designed to test the ability of
the carbon nanoparticles to directly activate the MΦ.
Cell cytotoxicity assessments demonstrated that both chronic “exposure” and “preexposure” to BC significantly decreases cell viability, in contrast, MWCNT showed no cytotoxic
response, consistent with the treatment controls. Similarly, previous in vitro assays in our
laboratory have demonstrated a cytotoxic response with long term (7 and 14 day) treatment of
BC (Murr et al. 2006). The differences in cytotoxicty between the two test particles might be
dependent on carbon nanoparticle structure and aggregation properties. BC is characterized
by spherule graphite sheets and branched aggregates of carbon (Sellers et al. 2009), whereas,
MWCNTs consist of hollow cylinder like shapes composed of various layers of thin sheets of
graphene (Soto et al. 2005). Previously published studies (Murr et al. 2006, Murr et al. 2008,
Soto et al. 2007) show that various aggregated nanoparticles are toxic to cellular systems.
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These nanoparticles can overwhelm the biological system by penetrating deep into the lungs,
compromising airway clearance capacity, resulting in injury to the lung tissue (Buzea et al.
2007). In conclusion, cytotoxic assessments demonstrate that nanomaterials exhibit higher
toxicity to immune cells than larger particles and this activity might be a result of differences in
structure, composition and aggregation of particles. Therefore, it is critical to further study the
potential implications nanomaterials such as BC and MWCNT might have on adaptive immune
responses.
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CHAPTER 3
CHRONIC EXPOSURE TO BLACK CARBON COMPROMISES
MACROPHAGE RESPONSES TO MICROBIAL STIMULUS

3.1

INTRODUCTION
Nanotechnology is defined as research and technology development at the atomic,

molecular, and macromolecular scale, leading to the controlled manipulation and study of
structures and devices with length scales in the 1 to 100-nanometer (nm) range (McNeil,
2005).

Due to their small size and their particular physiochemical properties, research

indicates that toxicological profiles of nanoparticles may be significantly different from those of
larger particles composed of the same materials (Card et al. 2008). Research demonstrates
that ultrafine or nanoparticles pose a much greater health risk than fine and course particulate
matter (PM) (Donaldson et al. 2001; Donaldson et al. 2004; Machado et al. 2011; Murr et al.
2008; Nel et al. 2006; Oberdorster et al. 1994; Oberdorster, 2001; and Somasundaran et al.
2010) and that these nano-sized particles are able to disturb biological systems at the cellular
and subcellular levels (Kang et al. 2008).
Disruption of biological activity is of increasing concern as exposure to nanomaterials is
becoming more common. People are exposed to large numbers of ambient nanoparticles on a
daily basis due to environmental air pollution (Donaldson et al. 2004). Such materials are
generated by industrial sources, emissions from automobile combustion engines, and from
natural sources resulting from combustion processes such as forest fires and volcano
emissions (Oberdorster et al. 2005 and Card et al. 2008). Engineered nanomaterials also
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serve as environmental contaminants.

Such materials are commonly used in everyday

devices such as sporting goods, tires, stain-resistant clothing, sunscreens, cosmetics, and
electronics (Nel et al. 2006) and can be released into the environment during production or as
a result of use.
Nanoparticles are available in a variety of compositions such as metal-based (titanium
dioxide (TiO2), silicon dioxide (SiO2), tungsten (W), and nickel oxide (NiO)), or carbon-based
(fullerenes like C60 or black carbon (BC) and single-walled (SW) or multi-walled (MW) carbon
nanotubes (CNT)). The most abundant nanomaterial in both indoor and outdoor environments
is the carbon-based nanoparticles (Murr and Garza 2009). BC nanoparticles predominantly
form through anthropogenic activities such incomplete combustion. However, engineered BC
is also released to the environment. It is commonly used in the production of tires as a
strengthening agent and thus is released as tire wear debris (Murr, 2008). Carbon nanotubes,
such as MWCNT, are commercially engineered for their electrical, thermal, and mechanical
properties (Murr et al. 2005). Interestingly however, MWCNT has been found together with BC
in both indoor and outdoor environments (Murr et al. 2005 and Murr 2008), as a consequence
of combustion of natural gas, propane, wood, and candle (Murr and Garza 2009). Thus,
carbon nanoparticles present a fairly common exposure risk.
Exposure to carbon nanoparticles has been reported to induce pulmonary toxicity (Lam
et al. 2004; Warheit et al. 2004; Jia et al. 2005; Muller et al. 2005; Shevedova et al. 2005), as
well as exacerbate respiratory and cardiovascular diseases (Li et al. 2007). Studies examining
both anthropogenic and engineered carbon nanoparticles on human and murine cell lines have
reported that these materials are cytotoxic, increase oxidative stress by generating reactive
oxygen species (ROS), and promote inflammatory responses by production of pro-
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inflammatory cytokines (Garza et al. 2008; Soto et al. 2005; Soto et al. 2006; Soto et al. 2007;
Soto et al. 2008a; Soto et al. 2008b). These studies all suggest that environmental exposure
to anthropogenic as well as engineered carbon nanoparticles can have detrimental effects on
human health.
Animal experiments have supported the premise that exposure to airborne carbon
nanomaterials is detrimental. Long-term in vivo inhalation assessments of carbon
nanoparticles demonstrate an increase in systemic inflammation by production of proinflammatory cytokines and an increase in granulomatus inflammation in lungs and draining
lymph nodes of treated animals (Lam et al. 2004).

Data also suggests that respiratory

exposure to BC might influence the exacerbation and development of inflammatory conditions
of the airways such as chronic obstructive pulmonary disease (COPD).

In addition to

promoting inflammation, inhaled BC particles have been shown to induce oxidative stress
causing cellular cytotoxicity and lung injury (Donaldson et al. 1998). Data also demonstrate
that carbon nanoparticles acquired through chronic inhalation are difficult to clear by
phagocytic cells leading to low clearance of these particles from the airways (Barlow et al.
2008). Interestingly, animal studies demonstrate translocation of inhaled carbon nanoparticle.
Nano-size carbon particles have been shown to translocate from the alveolar region to the
circulatory system followed by distribution throughout the body, including the vasculature,
heart, liver, spleen, and bone marrow (Geiser and Kreyling, 2010; Kreyling et al. 2009;
Nemmar et al. 2002; and Peters et al. 2006). However, only a low percentage of the carbon
nanoparticles were able to translocate from the alveolar region to the circulatory system,
indicating a low clearance mechanism for these nano-sized particles from their initial
deposition site.

Nevertheless, nanoparticle access to different tissues in the body could
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explain why exposure to ambient carbon nanoparticles has been associated with health
conditions such as cardiovascular diseases (Li et al. 2007).
Ambient carbon nanoparticles present a particularly unique health risk due to their
ability to penetrate deep into the lung and to possibly circulate into other organs. Retention of
carbon nanoparticles within tissues due to reduced clearance suggests interference with innate
immunity, notably macrophages (MΦ). MΦ are phagocytes, responsible for recognizing,
engulfing, and destroying potential pathogens. They are ubiquitously located in many tissues
such as the skin, lungs, spleen, lymph nodes, and liver, where they serve as filters for trapping
foreign material (Palomaki et al. 2010). When foreign material is encountered, MΦ can become
activated; in this state they increase phagocytosis as well as up-regulate nitric oxide (NO)
production and cytokine secretion, all of which are involved in the removal of invading
pathogens (Javala et al. 2008 and Xaus et al. 2000). MΦ are typically activated by toll-like
receptor (TLR) ligands, which are pathogen-associated molecules, (Stout and Suttles, 1995) or
by cytokines secreted by T cells such as interferon-gamma (IFN- γ). MΦ also serve as antigen
presenting cells (APC), processing and presenting peptide antigen of ingested material to T
cells that have migrated into the site of infection. Activation of primed T cells completes
elimination of the invading pathogen. Thus, activated MΦ are able to act as scavenger cells,
kill microbial pathogens, secrete inflammatory cytokines for the recruitment of other immune
cells, and to activate primed T cells (they also participate in tissue repair) (Xaus et al. 2000).
Previous studies demonstrating that carbon nanomaterial is predominantly retained in
situ suggest that MΦ phagocytic ability is reduced by the presence of fine and course
particulate matter hence affecting the clearance of the particles from the alveolar region of the
lung (Barlow et al. 2008). Thus, considering that MΦ are critical for effective microbial
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eradication, inhaled nanomaterials could severely inhibit anti-microbial immunity. Here, we
assess the effect of carbon nanoparticles BC and MWCNT on MΦ function in an in vitro
chronic exposure model. The data demonstrate that BC by itself, in a chronic “exposure”
model, is capable of inducing an inflammatory response by murine MΦ as measured by NO
formation and TNFα production. Additionally, in a “pre-exposure” model, BC suppresses MΦ
activity in relation to adaptive immunity. The up-regulation of cell surface MΦ activation
markers, required to interact with T cells, was prevented by “pre-exposure” to BC; moreover,
BC “pre-exposure” suppressed phagocytosis (antigen acquisition), and prevented proteolytic
processing of ingested material (antigen processing). In contrast, MWCNT causes little or no
effect on murine MΦ. Thus, our data demonstrate that BC can promote innate immune activity
and inhibit adaptive immune function of MΦ suggesting that carbon nanoparticles could
potentially alter the effectiveness of alveolar MΦ to clear pulmonary infections.

The data

further suggests that this phenomenon might be dependent on carbon nanoparticle structure
since MWCNTs demonstrated no impact on MΦ function.

The findings underscore the

potential detriment that carbon-based nanoscale air pollutants can impose on immunity.

3.2

METHODS
Carbon nanomaterials. Black carbon (BC) (Vulcan XC-72) from Cabot Corporation

(Billerica, MA) and multi-walled carbon nanotubes (MWCNT) powder purchased from Rosseter
Holdings, Inc (Limassol, Cyprus) were used for our experiments. Both carbon nanoparticles
have been characterized by Soto et al. (2005) by transmission electron microscopy (TEM)
using a Hitachi H-8000 analytical TEM operated at 200kV accelerating potential and fitted with
a goniometer-tilt stage, and a noran energy-dispersive (X-Ray) spectrometer (EDS). Carbon
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nanoparticles were suspended in a stock solution at 5 mg/mL in dimethyl sulfoxide (DMSO)
(Sigma-Aldrich, St. Louis, MO). The solutions were re-suspended, prior to administration to
the cells, using a vortex (1 min) to minimize carbon nanoparticle agglomeration.
Cell line.

Murine macrophage RAW264.7 (TIB-71) cells were obtained from the

American Type Culture Collection (ATCC, Manassas, VA). Cells were cultured at 37 C and
5% CO2 in Dulbecco’s Modified Eagle Media (DMEM), supplemented with 10% fetal bovine
serum (FBS), 5% penicillin-streptomycin, 5% sodium pyruvate, and 5% glutaMAX from Fisher
Scientific (Pittsburg, PA).
Viability assay. The viability of RAW264.7 cells after exposure to BC and MWCNT
was assessed by CellTiter Glo luminescent assay as described by the manufacturer (Promega
Corporation, Madison, WI). The CellTiter Glo assay is a luminescent method for distinguishing
the number of viable cells in culture based on quantification of adenosine-5’-triphosphate
(ATP), which signals the presence of metabolically active cells. In brief, 4 x 105 cells per well
were seeded in 6-well plates (Midwest Scientific, St. Louis, MO ) and allowed to attach the
surface for 24 h prior to carbon nanoparticle exposure. Subsequently, carbon nanoparticles
(MWCNT’s and BC at 30 µg/mL) and DMSO (vehicle control) were added for 48 hr. Following
exposure, the cells were harvested, centrifuged, and re-suspended in 1 mL of complete
DMEM; 100 µl of cell suspension was transferred to opaque-walled 96-well plate (VWR,
Radnor, PA) in replicates of eight. An equal volume of the Cell Titer Glo substrate was then
added to each well. The plate was then placed on a shaker for two minutes to induce cell
lysis. Next, viability was measured as a function of relative light units (RLU) using a microplate
luminometer (Luminoskan Ascent, Thermo Scientific).
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Cytokine assay. Pro-inflammatory cytokine production (tumor necrosis factor alpha TNFα) by RAW267.4 cells and interferon gamma (IFNγ) production by T cells was measured
using commercially available enzyme-linked immunosorbent assay (ELISA) kits (BioLegend,
San Diego, CA). The ELISA analysis was performed according to manufacturer’s instructions.
Briefly, microtiter ELISA plates were coated with capture antibody over night at 4 C. The
plates were then blocked at room temperature with 3% bovine serum albumin in PBS. Cell
culture supernatants from treated MΦ or from T cell and MΦ co-cultures were added to the
plates. Following binding of cytokines to the capture antibodies, the plates were incubated with
biotin-conjugated anti-cytokine antibody, followed by HRP-labeled avidin (Biosource/Life
Technologies, Grand Island, NY). The chromogenic substrate 3,3’5,5’-tetramethylbenzidine
(TMB) (Genscript, Piscataway, NJ) was utilized for color development and absorbance was
measured by microplate spectrophotometer (VersaMax Microplate Reader, Molecular
Devices). Cytokine concentrations were calculated against murine recombinant cytokines (BD
Pharmingen, San Jose, CA).
Nitric oxide assay. Nitric oxide (NO) formation was measured by the Griess Reagent
System (Promega Corporation, Madison, WI). This is a colorimetric assay that measures
nitrite (NO2-), the stable metabolite, in culture supernatants. 144 hr post carbon nanoparticle
treatment, culture supernatants were collected and placed into 96-well plate (Midwest
Scientific, St. Louis, MO). According to the manufacturer’s instructions, sulfanilamide and N-1napthylethylenediamine dihydrochloride (NED) solution were added to all samples, which gave
a purple/magenta color in the presence of (NO2-). Color change was detected by measuring
the absorbance in a microplate spectrophotometer (VersaMax Microplate Reader, Molecular
Devices) in the visible range at 520nm. Nitrite concentrations were calculated from a sodium
nitrite standard curve using a linear curve fit (SOFTmax Pro software, Molecular Devices).
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Measurement of cell surface activation molecules. Cell surface molecules CD40
and CD86 were analyzed by flow cytometry 144 hr after treatment with carbon nanoparticles.
RAW264.7 cells were gently removed from the plate surface by scrapping. After 2 washes
with ice cold FACS buffer (1X phosphate buffered saline (PBS), 2% FCS, and 0.1% sodium
azide) cells were blocked with 50% normal mouse serum for 20 min. This was followed by an
incubation with PE-conjugated anti-CD40 or anti-CD86 antibodies (BD Pharmingen, San Jose,
CA). After a 45 min incubation, the samples were washed with FACS buffer and cells were
fixed with 1% parafomaldehyde (PFA) (Sigma-Aldrich, St. Louis, MO) and analyzed via flow
cytometry (Beckman Coulter FC500 System).
Phagocytosis assay.

Phagocytosis activity was examined using the Vybrant

Phagocytosis Assay Kit (Invitrogen, Carlsbad, CA), which determines phagocytosis by the
internalization of fluorescently-labeled bio-particles. Briefly, cells were seeded at 1 x 105 cells
per well in a 96-well flat bottom black-walled plate (VWR, Radnor, PA) and incubated with
fluorescein-labeled Escherichia coli (E. coli) K-12 BioParticles. Following a 2 hr incubation at
37 C, the cells were treated with trypan blue to quench fluorescence of any E. coli bioparticles that were not uptaken by the RAW264.7 cells. Phagocytosis was analyzed with a
fluorescence plate reader (excitation 480 nm, emission 520 nm) (Fluoroskan Ascent, Thermo
Scientific).
Measurement of antigen processing. Antigen processing by treated RAW264.7 cells
was examined by the addition of a self- quenched conjugate of ovalbumin (DQ-OVA), which
exhibits bright green fluorescence upon proteolytic degradation due to the released dye
molecules (Invitrogen, Carlsbad, CA). According to the manufactures instructions, following
carbon nanoparticle treatment, cells were seeded at 1 x 105 cells per well in a 96-well flat
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bottom black-walled plate in the presence of DQ-OVA (10 µg/mL). Fluorescence emission
proportional to the extent of DQ-OVA processed was measured (excitation 485 nm, emission
518 nm) every 10 min for 320 min with a fluorescent plate reader (Fluoroskan Ascent, Thermo
Scientific).
Measurement of reactive oxygen species (ROS) production. ROS generation by
treated RAW264.7 cells was determined by flow cytometry using the CellROX™ Deep Red
(Invitrogen, Carlsbad, CA). The reagent is a cell permeant indicator for ROS; the reagent is
non-fluorescent while in a reduced state and upon intracellular oxidation it exhibits a
fluorescent signal. After 144 hr carbon nanoparticle treatment, the cells were gently scraped
and transferred to flow cytometry tubes.

According to the manufacturer’s instructions,

CellROX™ Deep Red Reagent was added to each tube at a final concentration of 5 µM and
incubated for 30 min at 37 C. The medium was then removed and cells were washed three
times with PBS followed by fixation with 1% PFA. The samples were analyzed via flow
cytometry (excitation 640 nm, emission 665 nm) (Beckman Coulter FC500 System).
Antigen presentation to antigen-specific T cells. To observe the ability of treated
RAW264.7 cells to process whole protein and present processed peptides to T cells, carbon
nanoparticle-treated MΦ cells were pulsed with soluble endotoxin-free ovalbumin protein (250
µg/mL) (BioVendor, Candler, NC) and were irradiated in a X-RAD 160 Biological X-Ray
Irradiator (Precision X-Ray, North Branford, CT) at 3,000 cGy per min . Irradiated MΦs were
then co-cultured with enriched ovalbumin-specific CD4+ T cells isolated from lymph nodes of
C.Cg-Tg(DO11.10)10Dlo/J mice (The Jackson Laboratories, Bar Harbor, ME) at a ratio of 1:10
MΦ to T cell for 72 hrs in a flat bottom 96-well plate (Midwest Scientific, St. Louis, MO). T cell
activation was measured 72 hrs later as a function of IFN- γ production by ELISA.
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Statistical Analysis. The data is presented as the mean ± SEM of replicate wells and
is one of three representative experiments. The differences among treatment groups was
evaluated using one-way ANOVA with a post-hoc Tukey test with a significance level of
p<0.05. (GraphPad Prism software v. 5.00, San Diego, CA).

3.3

RESULTS
In this study we have examined two distinct engineered nanoparticle materials, Vulcan

XC-72 black carbon (BC) (Figure 8A) and MWCNTs (Figure 8B). BC is a common
nanoparticle composed of more than 97% elemental carbon, characterized by spherule
graphite sheets of carbon (Sellers et al. 2009) (Figure 8A). Its initial particle size is nano-size;
however, van der Waals forces cause BC particles to aggregate and eventually adhere to form
stable agglomerates that can reach 1 to over 100 µm in size. A different shaped carbon
nanoparticle is carbon nanotubes (CNTs) (Figure 8B); these are known for their cylinder/fiber
like shape and strong structural properties. CNTs are categorized as single-walled carbon
nanotubes (SWCNTs) or multiwalled (MWCNTs).

SWCNT consist of hollow cylinder like

shape composed of one layer thin sheet of graphene, while MWCNTs are made of various
layers.
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Figure 8. TEM image of commercially produced Carbon Nanoparticles. Black Carbon (BC) containing
spherule and branched aggregates (A) and Multi-Walled Carbon Nanotubes (MWCNT) aggregate
material (B).

The carbon nanoparticle materials used in this study were previously characterized by
Soto et al. (2005) and (2006). Transmission electron microscopy (TEM) and ancillary
techniques involving selected-area electron diffraction (SAED) to observe the particle
crystallinity were performed for both carbon nanoparticles.

As previously described,

engineered BC nanoparticles are composed of branched aggregates of carbon spherules
ranging in size from 2 to 50 nm; with a mean diameter of 20 nm; and SAED patterns show
carbon spherules to be composed of graphene (graphite sheet nano-fragments). Engineered
MWCNT nanoparticle aggregate sizes ranged from 10 nm to 30 nm and nanotube lengths
ranged from 50 nm to >1 µm. SAED patterns show clumps or loose aggregates composed of
multi-wall nanotubes and other carbon nanoforms (fullerene polyhedra). In addition to
engineered nanomaterial, Soto et al.

(2005) characterized anthropogenic carbon
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nanoparticles.

TEM and SAED demonstrated that anthropogenic BC and MWCNT

nanoparticles are identical in morphology and composition to the engineered materials.
Garza et al. (2008) performed in vitro cytotoxicity assays with these nanomaterials using
a human lung epithelial cell line (A549) as the indicator system. They observed significant
cytotoxicity in response to the engineered BC and MWCNT and to various anthropogenic
nanomaterials. Thus, the similarities in structure composition and cytotoxicity establish the
grounds for using manufactured carbon nanoparticles for the current study. Moreover, these
previous studies suggest that the similar cytotoxicity between the engineered and
anthropogenic carbon nanomaterials deserve further investigation since the carbon
nanoparticles could potentially lead to long term complications and exacerbations of
respiratory diseases (Soto et al. 2005).
In this study, murine MΦs were chronically exposed in vitro to BC and MWCNT to
assess the affects of these nanomaterials on MΦ function and clearance mechanisms. The in
vitro model allowed us to evaluate, in a controlled and simple experimental model, the potential
effect of engineered carbon nanoparticles on MΦ’s and by inference, how the environment and
anthropogenic activities may influence innate immunity. Two chronic six-day exposure models
were established, “pre-exposure” and “exposure”. The “pre-exposure” model was formulated
to investigate the potential ability of carbon nanoparticles to alter MΦ responses to future
microbial insults; the “exposure” model was designed to test the ability of the carbon
nanoparticles to directly activate the MΦ.
Figure 9 outlines the experimental set-up for the chronic in vitro model.

Murine

macrophage-like cells, RAW264.7 were used as the model system. The cells were divided
into the following treatments: media (negative control), media stimulated (lipopolysaccharide,
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LPS 100 ng/mL – positive control), MWCNT treated (30 µg/mL), BC treated (30 µg/mL), and
dimethylsulfoxide (DMSO) treated (vehicle control). On day 0, MΦ were plated into 6-well
plates at 4 x 104 cells per well. The following day (day 1), carbon nanoparticles (BC and
MWCNT) and vehicle control (DMSO) were added to the indicated wells. On day 4, the cells
were washed with phosphate buffered saline (PBS) and treatments were refreshed.
Subsequently, on day 6, the cells were washed with PBS and treatments were refreshed.
Additionally on day 6, but only for the “pre-exposure” set of plates, lipopolysacharide (LPS -100
ng/mL) stimulus was added to all treatments except to the negative control. The administration
of LPS functioned as a mimic for a bacterial infection following a chronic exposure to the
carbon nanoparticles. Alternatively, on day 6 for the “exposure” model, LPS (100 ng/mL)
stimulus was only added to the positive control. This series of plates assessed the impact of
chronic exposure, in the absence of infection, on the MΦ. Twenty-four hrs later, on day 7, the
function of the MΦs were assessed for both “pre-exposure” and “exposure” models.
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Figure 9. Chronic in vitro assay model. On day 0, MΦs are be plated in 6-well plates at 4 x 10 cells per
well. The next day (d1), carbon nanoparticles (MWCNT’s and BC) and vehicle control (DMSO) is added
to the indicated wells and left in the incubator for 72 hrs. On d4, cells are washed with 1X PBS and
treatments are refreshed; the cells are incubated for an additional 48 hrs. Subsequently, on d6, the
cells are again washed with 1X PBS and treatments are refreshed. For the “pre-exposure” set of
plates (A), LPS (100 ng/mL) stimulus is added to all treatments except the negative control. For the
“exposure” model (B), the LPS (100 ng/mL) stimulus is added only to the positive control. Twenty
four hours later (d7), the cells from both the “pre-exposure” and “exposure” plates are assessed for
cell viability, TNFα production, NO formation, ROS production, phagocytosis ability, and upregulation of MF cell surface markers.

To study the cytotoxicity effects of MWCNT and BC particles on MΦ and to determine
the concentration of the particles to use in the chronic experiments, a dose response viability
assay to an acute exposure was first performed. MΦ were exposed for 48 hr to increasing
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concentrations of carbon nanoparticles, MWCNT and BC (10 µg/mL to 100 µg/mL), and
assessed for viability by the CellTiter Glo assay.

The luminescent-based assay was

specifically selected to eliminate interference of the carbon materials with a colorimetric-based
assay. Results demonstrated that BC and MWCNT carbon nanoparticles are cytotoxic to the
MΦ in a dose dependent manner. Additionally, the cytotoxic assessment demonstrated that
BC alters MΦ cell viability with an LC50 of 30 µg/mL. The results also demonstrated that BC is
markedly more cytotoxic than MWCNT. Previous MWCNTs anthropogenic collection studies
(Soto et al. 2005) indicate that this carbon nanoparticle is found in low concentrations in the
environment, which makes it difficult to collect in sufficient quantities to perform adequate
assays. Thus, rather than use MWCNT at its LC50, which would have been significantly high
and likely not realistic to environmental exposure doses, we chose to keep MWCNT at the
same concentration as the BC LC50.
MΦ also produce inflammatory mediators as a protective response or defense to
eliminate foreign material or organisms that cause injury. Mediators include nitric oxide (NO),
pro-inflammatory cytokines such as tumor necrosis factor alpha (TNFα), interleukin molecules
(IL) IL-6, and IL-12, and chemokines (CC and CXC) (He et al. 2008 and Javala et al. 2008).
Results from chronic “exposure” treatment in Figure 10A and 10B demonstrate an upregulation in the formation of pro-inflammatory mediators NO and TNFα. However, no
statistical difference was observed in the detection levels of NO and TNFα formation in chronic
“pre-exposure” model (Figure 10C and 10D). The data indicates that BC by itself is capable
of inducing an inflammatory response in murine MΦ by up-regulating NO formation and TNFα
production, however MWCNT does not. In addition, neither BC nor MWCNT inhibit NO or
TNFα production upon microbial stimulation.
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Figure 10. BC Chronic “exposure” up-regulates NO and TNFα formation in MΦ. MΦs were treated with
MWCNT or BC and were tested for Nitric Oxide formation (A, B) and TNFα production (C, D) 7 days
post-treatment. However, BC Chronic “Pre-Exposure” does not alter MФ inflammation markers (C)
and (D). This data is presented as the mean ± SEM of duplicate wells and is one of three
representative experiments.

Intracellular production of reactive oxygen species (ROS) is also an important defense
mechanism to mediate microbial clearance; however, over production of ROS can overwhelm
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the cellular antioxidant capacity (Xia et al. 2006). Studies have implicated ROS formation as a
cytotoxicity mechanism promoted when cells come into contact with the surface of carbon
nanoparticles, creating an oxidative stress reaction, which is a state of redox disequilibrium (Li
et al. 2008). In Figure 11A, we observed that BC “pre-exposure” significantly decreased ROS
production in murine MΦ.

Figure 11. BC Chronic “pre-exposure” alters MФ ROS production. MФ were treated with MWCNT or BC
and “Pre-Exposure” (A) samples were activated with 100ng/mL of LPS. Treatments were tested for
ROS production by CellROX™ Deep Red fluorescent reagent 7 days post-treatment. This data is
presented as the mean ± SEM of duplicate wells and is one of three representative experiments.

MΦ become activated and up-regulate expression of cell surface molecules when they
engage toll-like receptors upon encountering and interacting with foreign materials or
microbes. Activation molecules include CD80, CD86, and major histocompatibility complex
(MHC) class II antigen (MHCII).

These markers indicate MΦ activation and are used for

optimal interaction with primed T cells. Results in Figure 12A and 12B demonstrate that
chronic “pre-exposure” to BC nanoparticles caused an inhibition of cell surface MΦ activation
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markers CD40 and CD86; “exposure” alone did not induce up-regulation of these markers.
Thus, it was observed that BC inhibits MΦ response to a microbial stimulus by preventing the
increased expression of cell surface MΦ activation markers.

Figure 12. BC Chronic “pre-exposure” alters MФ response to LPS. MФ were treated with MWCNT or BC
and activated with 100ng/mL of LPS. Post-treatment, the cells were harvested, washed, and then
stained with PE-conjugated anti-CD40 (A) or anti-CD86 (B). This data is presented as the mean ± SEM
of duplicate wells and is one of three representative experiments.

MΦs are highly effective in the uptake of pathogens by phagocytosis, which serves two
functions; the removal of the invading microbe and maintenance of a T cell-mediated immune
response. Protein material ingested by MΦs is ultimately processed by proteolytic cleavage
into peptides for antigen presentation to primed T cells. Studies indicate that chronic inhalation
of carbon nanoparticles are difficult to clear by phagocytic cells due to the constant overload in
the animal’s respiratory system (Barlow et al. 2008). We therefore also investigated antigen
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acquisition/phagocytosis and antigen processing by the RAW267.4 cells exposed to the
carbon nanomaterials.

Phagocytosis was measured as uptake of fluorescently-labeled

bioparticles; antigen processing was measured as intracellular exposure of fluorescentlylabeled ovalbumin (OVA-DQ: exposure of fluorescence occurs following proteolytic removal of
a protein cage). As shown in Figure 13A and 13B, after chronic “pre-exposure” to the carbon
nanoparticles, we observed a significant decrease in phagocytosis and OVA-DQ processing by
the BC treated MΦ. Results demonstrate that pre-exposure to BC severely compromises the
ability of MΦs to ingest and degrade extracellular material.

Figure 13. BC Chronic “pre-exposure” alters MФ antigen acquisition and processing. MФ were treated
with MWCNT or BC and were additionally activated with 100 ng/mL of LPS. The cells were tested for
Phagocytosis (A) and OVA-DQ processing (B) post-treatment. The data is presented as the mean ±
SEM of duplicate wells and is one of three representative experiments.

MΦs are an important component of the innate immune system, as phagocytes these
cells internalize and digest pathogens. This process ultimately leads to antigen presentation
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and links MΦs to adaptive immunity. MΦs thus activate the adaptive immune system by
breaking down antigens and binding of protein fragments (peptides) to MHC class II molecules
that are then sent to the cell surface for presentation to primed T cells (Russell and Gordon
2009 and Underhill et al. 2009). In this way, MΦs engage primed T cells that have entered the
site of infection, promoting pathogen clearance by adaptive immune cells (Russell and Gordon
2009 and Underhill et al. 2009). Figure 13 demonstrated that acquisition and processing of
antigen is suppressed by pre-exposure to BC. We therefore investigated the ability of carbon
nanoparticle treated RAW267.4 cells to process and present soluble endotoxin-free ovalbumin
protein (250 µg/mL) (BioVendor, Candler, NC) to ovalbumin protein-specific CD4+ T cells
(Figure 14A). The antigen-specific processing and presentation (APC – T cell interaction)
results indicate a decrease (although not statistically significant) in T cell response (IFN-γ
production) when MΦ are pre-treated with BC, indicating a suppressed ability to effectively
acquire and/or process ovalbumin protein. Addition of ovalbumin protein requires the
internalization by phagocytosis, proteolytic processing of protein and up-regulation of MHC
class II peptides at the cell surface. As shown in Figure 14A, the positive controls pre-treated
cells readily interact and activate T cells. Thus, the decreased induction of IFNγ by T cells
when co-cultured with BC pre-treated MΦ is directly related to the MΦs inability to effectively
phagocytose and/or process protein antigens.
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Figure 14. Chronic “Pre-Exposure” to BC suppresses MФ antigen processing and presentation. MФ were
pre-treated with MWCNT or BC and were additionally activated with 100 ng/mL of LPS. 7 days post
treatment the cells were irradiated and given endotoxin-free ovalbumin protein (250 µg/mL) (A). The
+
cells were then used as antigen presenters to ovalbumin-specific enriched CD4 T cells harvested
from C.Cg-Tg(DO11.10)10Dlo/J mice. T cell responses were measured as a function of IFNγ
production 96 hrs post-co-culture. The data is presented as the mean ± SEM of five wells and is one
of three representative experiments.

3.4

DISCUSSION
The present study demonstrates in vitro chronic exposure to BC nanoparticles alters

MΦ function by promoting inflammation and compromising responses to microbial stimulation.
Results indicated that BC by itself is capable of inducing an inflammatory response in murine
MΦ by up-regulating TNFα alpha production and NO formation.

Exposure to carbon

nanoparticles such as BC has previously been shown in both in vitro and in vivo to increase
the production of pro-inflammatory cytokine TNFα (Brown et al. 2002, Muller et al. 2005,
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Donaldson et al. 2003, Pozzi et al. 2003, Monteiller et al. 2007). Similarly, Brown et al. (2002)
reported that treatment with ultrafine BC (nanomaterial) resulted in TNFα increase in rat
alveolar MΦ while other in vitro studies observed increases in TNFα production in the
supernatants and mRNA levels of MΦ cultures (Muller et al. 2005). Additionally, Donaldson et
al. (2003) treated human MΦ cells (MM6) and rats with BC nanomaterials and observed an
increase in TNFα cytokine release and greater inflammation in the rat model. Furthermore,
Pozzi et al. (2003) tested the induction of pro-inflammatory mediators by treating RAW264.7
MΦ cells with urban air particles and BC and observed an increase in TNFα production.
Continuous secretion of TNFα has been linked to an increase inflammatory response with
resulting pathological consequences (Brown et al. 2007). In addition, it has been reported that
BC nanoparticles and TiO2 exhibited pro-inflammatory effects on epithelial cells in vitro
(Monteiller et al. 2007) and several studies have also indicated NO formation as a marker for
inflammatory responses. Stoker et al. (2008) reported an increase in NO formation using
human bronchial epithelial cells and human lung fibroblast exposed to carbon nanomaterials.
Similarly, Park and Park (2009) investigated pro-inflammatory responses using in vivo and in
vitro murine models treated with silica nanoparticles reporting an increase in NO formation, upregulation of mRNA inflammatory related genes and cytokines in both models. A constant
inflammatory response could potentially be detrimental to the immune system by causing
systemic inflammation (Lam et al. 2004) as well as influencing health conditions such as
pulmonary and cardiovascular diseases (Li et al. 2007).
Next, we compared the effects of carbon nanomaterial exposure on immune cells pretreated with LPS to test the ability of a bacterial infection to suppress MΦ activity. Several
studies have investigated the effects of BC nanomaterials and the mechanism by which they
influence cell and animal toxicity by testing for oxidative stress by generation of intracellular
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ROS (Donaldson et al. 2001 and 2003; Garza et al. 2008; Kagan et al. 2006; Koike and
Kobayashi, 2006; Pulskamp et al. 2007; Shatkin, 2008; Shvedova et al. 2005; Soto et al.
2008a; Xia et al. 2006; Wilson et al. 2002). In contrast to several studies which indicate that
BC nanomaterials can increase oxidative stress by the formation of ROS, our results indicate
that BC “pre-exposure” to LPS inhibited ROS formation.

Other studies also noticed the

absence of intracellular ROS formation (Shvedova et al. 2005 and Crouzier et al. 2010) and
suggest that it is due in part to the purity of the nanoparticles that were metal free structures
(Cruzier et al. 2010). Furthermore, a recent study with engineered fullerenes (C60) on human
epidermal keratinocyte cells (HEK) reported an inhibition in total ROS levels (Gao et al. 2010).
The authors showed that engineered fullerene (tris-C60) induced cellular senescence, inhibited
apoptosis and necrosis, cell proliferation, reproductive capacity, and cell cycle arrest. They
suggest these effects could be the consequence of chemical modification of the engineered
fullerene since the other two tested fullerenes did not exhibit cellular senescence.

The

discrepancy between ROS production studies could then be partly due to the functionalization
and purity of the carbon nanoparticles being tested.
Co-stimulatory molecules CD40 and CD86 are involved in antigen presentation and play
an important role in host defense when MΦ are activated (He et al. 2008 and Suttles and
Stout, 2009). Activated MΦ cells treated with LPS up-regulate the expression of these cell
surface receptors which allow for the interaction with ligands on T cells in order to present
foreign antigen (He et al. 2008 and Becker et al. 2003). Few studies have compared the role
and importance of adaptive immune responses to carbon nanoparticle exposure.

These

studies have reported that exposure to nanomaterial by itself can act as a stimulus resulting in
increased expression of co-stimulatory molecules (CD80, CD86, and CD40) (Becker et al.
2003; de Haar et al. 2008; Koike et al. 2008; and Palomaki et al. 2010). In sharp contrast, our
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findings indicate that chronic BC “pre-exposure” to LPS inhibited cell surface marker
expression (CD40 and CD86).

Recent in vitro studies on mouse MΦ and bone-marrow

derived dendritic cells treated with carbon nanoparticles, exhibited an increase in the
expression of co-stimulatory molecule CD86 (Palomaki et al. 2010). In addition, Koike et al.
(2008) treated bone marrow derived dendritic cells with BC nanoparticles for 24 hrs and
demonstrated an increase in the percentage of cells expressing CD86 and MHC class II and
not CD80, suggesting that BC nanoparticles could potentially activate DCs. Furthermore, in
vitro primary human alveolar MΦ studies observed that exposure to ultrafine particulate matter
(nanomaterial) collected from the ambient air had no effect on co-stimulatory molecules
(CD40, CD80 or CD86) (Becker et al. 2003). However, using human blood derived monocytes,
the authors showed that ultrafine particulate matter (nanomaterial) increased the expression of
these co-stimulatory molecules, suggesting that the phenomenon might be dependent on the
cell type. Differently from our results, the latter studies were performed on DCs and not MΦ,
nanomaterial exposure time was short-term (24 or 48 hrs), whereas our study exposed MΦ
cells to carbon nanomaterials for 144 hrs followed by LPS treatment. These results suggest
that chronic BC pre-exposure to LPS might affect MΦ cells antigen presenting capacity by
inhibiting expression of these cell surface markers.
MΦ are phagocytes, responsible for recognizing, engulfing, and destroying potential
pathogens through phagocytosis. In the present study, we demonstrate that BC pre-treatment
suppressed phagocytosis (antigen acquisition) in murine MΦ cells. The results of this study are
in accordance with others, for example, Lundborg et al. (1999) primed rat alveolar MΦ with
IFNγ followed by exposure to carbon nanomaterial. IFNγ as well as LPS are a MΦ activator
and can be used to mimic an infection (Hu et al. 2008). Their study demonstrated a marked
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inhibition in phagocytosis in rat alveolar MΦ cells primed with IFNγ and exposed to ultrafine
carbon particles (nanomaterial) for 6 hrs, however, no difference was observed in the cells that
were treated with ultrafine carbon particles (nanomaterial) without IFNγ. The authors suggest
that inhaled nanomaterial can gravely affect alveolar MΦ ability to properly remove ingested
particles mainly after exposure to infection. Moreover, several in vitro murine MΦ studies
(Donaldson et al. 2001, Donaldson et al. 2003, Renwick et al. 2001, Moller et al. 2002) and
human alveolar MΦ studies have reported inhibition of phagocytosis after treatment with
ultrafine carbon particles (nanomaterials) (Lundborg et al. 2001 and 2006). Donaldson et al.
(2001 and 2003) reported that treatment of J774A.1 murine MΦ cell line with ultrafine BC
(nanomaterials) inhibited phagocytosis.

The authors suggest that after MΦ exposure to

nanomaterials there is impairment in phagocytosis that leads to a release of inflammatory
mediators and increase in oxidative stress caused by the large surface area of nanomaterials
(Donaldson et al. 2001). Similarly, Renwick et al. (2001) indicated that treatment with ultrafine
BC (nanomaterials) (.39 µg/mm2) after 8 hr exposure impaired phagocytosis ability in J774.2
murine MΦ cells. The authors suggest that cell-cell contact is the mechanisms responsible for
the inhibition in phagocytosis and further report that interaction between MΦ cells and ultrafine
BC (nanomaterials) causes cells to transmit an inhibitory signal that prevents phagocytic
activity of cells with which they make contact (Renwick et al. 2001).

Additionally, they

demonstrate that inhibition of phagocytosis is particle dependent because both ultrafine TiO2
(nanomaterials) as well as ultrafine BC (nanomaterials) were tested, however ultrafine TiO2
showed no difference. Moreover, in vitro studies on J774A.1 murine MΦ cells and primary
alveolar MΦ from beagle dogs further demonstrate that exposure to ultrafine particles
(nanomaterial) (100 µg/ml), specifically BC nanomaterial causes cytsokeletal dysfunction such
as inhibition of phagocytosis abilities, however other nanomaterials such as TiO2 does not
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(Moller et al. 2002). Taken together, our findings suggest that uptake of BC nanoparticles by
MΦ treated with a microbial product (LPS) interferes with their clearance functions and ultimate
makes them incapable of adequately phagocytosing carbon nanoparticles that are coming into
contact with the surface of the cells.
While phagocytosing engulfed material, MΦ also serve as APCs, processing and
presenting peptide antigen of ingested material to T cells that have migrated into the site of
infection, thus activating an adaptive immune response (Xaus et al. 2000). To our knowledge
there are no published studies comparing the effect of carbon nanomaterial exposure on
immune cells treated with LPS and their ability to acquire and process antigen. Therefore we
investigated whether carbon pre-exposure to LPS would affect adaptive immune responses.
Our study demonstrated that acquisition and processing of antigen is suppressed by “preexposure” to BC. Furthermore, we observed a decrease (although not statistically significant)
in T cell response (IFN-γ production) when MΦ are pre-treated with BC. These results suggest
that decreased induction of IFNγ by T cells when co-cultured with BC pre-treated MΦ is directly
related to MΦs inability to effectively phagocytose and/or process protein antigens.
In contrast to BC nanoparticles, chronic “exposure” and “pre-exposure” to MWCNT
caused no detectable changes in MΦ function in any of our functional assays.

In sharp

contrast, others have reported significant cytotoxicity, inflammatory effects, oxidative stress,
ROS production (Bottini et al. 2006, Garza et al. 2008, Hirano et al. 2010, Sohaebuddin et al.
2010, Soto et al. 2008a), as well as suppression of systemic immunity in mice (Mitchell et al.
2009). It is likely that the variability in published results regarding MWCNT effects might be
dependent on the cell type, concentration, purity, degree of agglomeration, and exposure time.
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Taken together, our data demonstrates that chronic “pre-exposure” to carbon
nanoparticles, black carbon specifically, impedes MΦ response to microbial stimuli, which
could result in detrimental human health effects. If carbon nanoparticles are not cleared by
macrophages and are retained within tissues these could potentially lead to ineffective
pulmonary immunity. Understanding the key cellular responses to engineered carbon
nanoparticles can establish a strong framework in the study of how the environment and
anthropogenic activities influence and alter MΦ function, which may ultimately interfere with
effective pulmonary immune responses capable of increasing the development and
progression of human diseases like COPD.
In summary, we have demonstrated the BC by itself in a chronic “exposure” model is
capable of inducing an inflammatory response in murine MΦ by up-regulating NO formation
and TNFα production, however MWCNT does not. Moreover, our data also demonstrates that
BC inhibits MΦ response to a microbial stimulus by down-regulating cell surface MΦ activation
markers, phagocytosis, antigen processing, and ROS. Currently, the knowledge about the
immune response of APCs to carbon nanoparticulate materials is poorly understood,
additionally many biological aspects of specific constituents of nanoparticulate matter still
remains unclear and requires further evaluation. However our study indicates that there is a
dose dependent chronic exposure of RAW264.7 cells to BC inhibits MΦ response to a
microbial stimulus, whereas MWCNT causes little or no effect on murine MΦ. Additionally, no
changes in antigen specific presentation were observed with BC or MWCNT with or without
microbial stimuli.

This study suggests that some but not all anthropogenic carbon

nanoparticles could alter the effectiveness of the immune systems innate response to future
infections. Moreover, the data suggests this might be dependent on carbon nanoparticles
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structure and concentration. This underscores the potential detriment that air pollutants can
impose on immunity.
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CHAPTER 4
EXTENDED DISCUSSION
4.1

DISCUSSION
In this dissertation we studied the chronic effects of carbon nanoparticle exposure on

murine MΦ function and clearance mechanisms. Our hypothesis stated that MΦ exposed to
carbon nanoparticles would not suffer immediate compromised function; however, long-term
exposure to the nanomaterial would alter MΦ ability to respond appropriately to microbial
stimuli resulting in compromised immunity. We demonstrated that chronic “pre-exposure” to
BC nanoparticles specifically inhibited MΦ response to microbial stimuli (lipopolysaccharide LPS). As a consequence, cell surface MΦ activation markers, ROS production, phagocytosis,
antigen processing and presentation, all of which are needed for effective microbial clearance,
were inhibited. Taken together, these data suggest that exposure to carbon nanoparticles
could potentially lead to ineffective pulmonary immunity.
The first objective was to determine the cytotoxic effects of micron-sized and nano-sized
metals. We determined that nanoparticles are markedly more cytotoxic to cells than micronsized particles of the same composition. This is likely due to their small particle size, which
makes them more potent than larger particles because of their higher surface area and
reactivity (Brauner et al. 2007).

Additionally, many nanoparticles can agglomerate and

increase their net size, which can potentially cause adverse health effects and affect the
effective dose on the cellular system (Oberdorster et al. 2005).
To further evaluate the cytotoxicity of nanoparticles, we turned our attention on two
distinct nanoparticles, BC and MWCNT. Both are found in the environment as a result of
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combustion processes and have been linked to adverse health effects. Our laboratory had
previously shown that there is a decrease in cell viability in RAW264.7 and A549 cells treated
for 48 hrs with BC or MWCNT (Murr et al. 2006, Soto et al. 2005). Short-term cytotoxic
assessments with RAW264.7 cells demonstrated that BC alters MΦ cell viability with an LC50
of 30 µg/mL and indicated that BC is more toxic than MWCNT. For that reason we established
two chronic six-day exposure models, “pre-exposure” and “exposure”. The “pre-exposure”
model was formulated to investigate the potential ability of carbon nanoparticles to alter MΦ
responses to future microbial insults; the “exposure” model was designed to test the ability of
the carbon nanoparticles to directly activate the MΦ. Cell cytotoxicity assessments
demonstrated that both chronic “exposure” and “pre-exposure” to BC decreases cell viability, in
contrast, MWCNT showed no cytotoxic response, consistent with the treatment controls. The
differences in cytotoxicty between the two test particles might be dependent on carbon
nanoparticle structure and aggregation properties, since BC nanoparticles aggregate and
adhere to the surface of MΦ cells as demonstrated by light microscopy (Figure 15). Our
cytotoxic assessments demonstrated that the pulmonary-derived cells exhibit higher toxicity to
nanomaterials than to the larger particles and this activity might be a result of differences in
structure, composition and aggregation of particles.
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Figure 15. Chronic exposure to both MWCNT & BC causes blasting and aggregation of MΦs. MФ were
treated with MWCNT or BC, vehicle control (DMSO), and negative control (untreated) and were
examined by light microscopy 7 days post treatment. (Magnification: 40x)

To further investigate the effects of carbon nanoparticles on murine MΦs we examined
cellular responses of MΦ associated with the toxicity to the engineered carbon nanoparticles
(MWCNT and BC).

This was assessed following acute (48hr) and chronic (144hr) “pre-

exposure” and “exposure” treatments. As previously stated, our “pre-exposure” model was
formulated to investigate the potential ability of carbon nanoparticles to inhibit MΦ responses
to microbial stimuli; our “exposure” model was designed to test the ability of the carbon
nanoparticles to directly activate the MΦs. The results demonstrated that acute (48 hr) “preexposure” and “exposure” to BC and MWCNT does not alter RAW264.7 MΦ activity. Thus, we
focused our studies on chronic (144hr) “pre-exposure” and “exposure” treatments. Results
demonstrated that in vitro chronic “exposure” to BC nanoparticles alters MΦ function by
promoting inflammation and compromising responses to microbial stimulation. The data also
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indicated that BC by itself is capable of inducing an inflammatory response from murine MΦ by
up-regulating TNFα production and NO formation.
We then compared the ability of MΦ chronically pre-treated with carbon nanomaterials
to respond to bacterial stimuli.

In contrast to several studies which indicate that BC

nanomaterials can increase oxidative stress by the formation of ROS, our results indicate that
BC “pre-exposure” inhibited ROS formation upon stimulation with LPS. Other studies also
noticed the absence of intracellular ROS formation (Shvedova et al. 2005 and Crouzier et al.
2010) and suggest that it is due in part to the purity and functionalization of the nanoparticles.
Our results also demonstrated that chronic BC “pre-exposure” inhibited cell surface marker
expression (CD40 and CD86). Activated MΦ cells treated with LPS typically up-regulate the
expression of these cell surface receptors that allow for enhanced interaction with T cells (He
et al. 2008 and Becker et al. 2003). These results suggest that chronic BC “pre-exposure”
prior to a microbial infection might negatively affect MΦ cells antigen presenting capacity by
inhibiting expression of these cell surface markers. Indeed, studies have demonstrated that
the absence or decreased expression of these key co-stimulatory molecules reduces the
effectiveness of T cell-mediated immunity (Clarke, 2000).
To determine the effect of carbon nanoparticles on MΦ antigen presenting capacity, we
examined phagocytosis by the internalization of fluorescein-labeled E. coli bio-particles. In
addition, we investigated antigen acquisition and processing by the addition of a self-quenched
conjugate of ovalbumin (DQ-OVA). We demonstrated that BC “pre-exposure” suppressed
phagocytosis, antigen–acquisition and processing in activated murine MΦ cells. Furthermore,
we assessed the ability of carbon nanoparticle treated RAW267.4 cells to process and present
ovalbumin protein to ovalbumin protein-specific CD4+ T cells. The antigen-specific presentation
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results indicate a decrease (although not statistically significant) in T cell response (IFN-γ
production) when MΦ are pre-treated with BC, indicating a suppressed ability to effectively
acquire and/or process ovalbumin protein.

Taken together, our findings demonstrate that

uptake of BC nanoparticles by MΦ stimulated with a microbial product TLR 4 ligand (LPS)
ultimately renders the macrophages incapable of adequately ingesting and degrading
extracellular material thus, interfering with their microbial clearance functions and ability to
properly present antigen to T cells.

However, chronic “exposure” and “pre-exposure” to

MWCNT caused no detectable changes in MΦ function in any of our functional assays.
Similar findings were made when using TLR 2 ligand (zymosan) as the microbial stimulus. It is
likely that the variability in results between BC and MWCNT might be dependent on carbon
nanoparticle physical, chemical, and aggregation properties.
In addition, we investigated MΦ intracellular localization of ingested carbon
nanoparticles after chronic treatment. Transmission electron microscopy (TEM) allowed us to
identify carbon nanoparticles internalization location within MΦ. Ultrathin sections of carbon
nanoparticle treated macrophage cells were cut, stained, and analyzed by TEM. Microscopic
examinations revealed aggregated BC nanoparticles located and stored inside large
cytoplasmic vacuoles (Figure A1). We did not observe carbon nanoparticles in any organelle
including the nucleus, mitochondria, or golgi apparatus. As such, our data is in contrast with
observations by previous studies, who found ultrafine particles inside the mitochondria (Li et al.
2003) or inside the nucleus (Geiser et al. 2005). In addition, TEM analysis of MΦ cells treated
with MWCNT did not indicate intracellular uptake or penetration of these nanoparticles (Figure
A2).
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Lastly, as we sought to determine a potential mechanism and examined the effect of
carbon nanoparticles treated MΦ on mitochondrial membrane permeability, viability (Live/Dead
and trypan blue exclusion), and stress responses (HSP70, iNOS, and Cox-2). Mitochondria
membrane potential by treated RAW264.7 cells was determined by flow cytometry using the
MitoProbe JC-1 assay kit (Molecular Probes, Eugene, OR). JC-1 dye measures accumulation
in mitochondria, indicated by red fluorescence.

Whereas, mitochondrial depolarization is

indicated by a shift from red to green fluorescence intensity because JC-1 dye cannot
aggregate in the mitochondria and stays in the cytoplasm where it fluoresces green (Molecular
Probes, Eugene, OR).

Results demonstrated that BC “pre-exposure” does not alter

mitochondria membrane potential (Figure A5). BC treated cells had polarized mitochondria as
revealed by red fluorescence, whereas there was no indication of depolarized mitochondria
when compared to the untreated and vehicle controls. Next we performed two additional
viability assays and compared the results to the initial CellTiter Glo viability assay shown in
Figure 7, which determines viability based on quantification of ATP. After a 7 day chronic
“exposure” and “pre-exposure” to MWCNT and BC, we assessed cellular viability by
LIVE/DEAD assay and trypan blue exclusion assay. The LIVE/DEAD assay is a two color
fluorescent assay that identifies live versus dead cells on the basis of membrane integrity and
esterase activity. As shown in Figure A6, results from the LIVE/DEAD assay demonstrate that
both “exposure” and “pre-exposure” to BC is cytotoxic to RAW264.7 cells.

However, no

statistical difference was observed for any other measurement. These results are consistent
with the trypan blue exclusion assay data (Figure A7).

Interestingly, all viability assays

demonstrate that both “exposure” and “pre-exposure” to BC is cytotoxic to MΦs, however, the
CellTiter Glo assay shows a much more significant decrease in viability, while the other two
assays demonstrate a decrease in viability but not as cytotoxic as previously indicated by the
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CellTiter Glo. The LIVE/DEAD and trypan blue exclusion assay are in accordance with our
microscopic observations and cell count numbers of all treatments the day of their analysis
where there were a significant number of live cells in our BC treated samples. Next, we
examined stress responses (HSP70, iNOS, and Cox-2) by western blot analysis. Results
revealed no up-regulation of HSP70 or presence of iNOS and Cox-2. In overall our results
demonstrate that BC treated MΦs have polarized mitochondria, meaning they are healthy,
LIVE/DEAD assay revealed that BC is cytotoxic to MΦs but there is still a high percentage of
live cells, and there was no up-regulation of stress responses. Taken together, these results
might suggest that “pre-exposure” to BC is causing MΦs to undergo cellular senescence. This
process limits the growth of cells but not necessarily the viability of the cell, meaning the cells
become unresponsive. In addition, cellular senescence inhibits proliferation and apoptosis,
activates cell cycle checkpoints, and prevents cell division by inducing cell cycle arrest (Gao et
al. 2010). We need to perform further experiments to determine if cellular senescence is
responsible for the inhibition of MΦs responses associated with chronic BC “pre-exposure”
observed in this study.
In sum, we have demonstrated that exposure to anthropogenic nano-sized particles
proves to be more cytotoxic than larger particles. Our study indicates that chronic exposure of
RAW264.7 cells to BC inhibits MΦ response to a microbial stimulus, whereas MWCNT causes
little or no effect on murine MΦ. Additionally, long-term accumulation chronic exposure, rather
than short-term acute exposure to carbon nanoparticles interactions have deleterious effects
on MΦ function. Exposure to BC nanoparticles by itself in a chronic “exposure” model is
capable of inducing an inflammatory response in murine MΦ by up-regulating NO formation
and TNFα production, however MWCNT does not. Inflammation brought upon by long term
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chronic exposure to anthropogenic carbon nanoparticles requires careful observation since
excessive inflammatory responses could further aggravate pre-existing diseases such as
respiratory or cardiovascular diseases. Moreover, our data also demonstrates that BC inhibits
MΦ response to a microbial stimulus by down-regulating cell surface MΦ activation markers,
ROS, phagocytosis, antigen processing and presentation to T cells.

Macrophage’s main

function is to engulf and process materials and thus create a link between innate and adaptive
immune system. If carbon nanoparticles are not cleared by macrophages and are retained
within tissues these could potentially lead to lung tissue injury and ineffective pulmonary
immunity. Thus, understanding the key cellular responses to engineered carbon nanoparticles
can establish a strong framework in the study of how the environment and anthropogenic
activities influence and alter MΦ function, which may ultimately interfere with effective
pulmonary immune responses capable of increasing the development and progression of
human diseases like COPD.

4.2

FUTURE DIRECTIONS
Currently, the knowledge about the immune response of APCs to carbon

nanoparticulate materials is poorly understood, additionally many biological aspects of specific
constituents of nanoparticulate matter still remains unclear and requires further evaluation.
This study suggests that some but not all anthropogenic carbon nanoparticles could alter the
effectiveness of the immune system’s innate response to future infections. Moreover, the data
suggests this might be dependent on carbon nanoparticles structure and concentration.
Although we do not know the exact mechanism of action by which carbon nanoparticles are
inhibiting macrophage function, we can conclude that long-term chronic BC “pre-exposure”
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impairs macrophage phagocytic and acquisition and processing abilities in vitro.

This

underscores the potential detriment that air pollutants can impose on immunity. Further
studies, should include assessment of cellular senescence by examining the expression of βgalactosidase, activation of cell cycle checkpoints, and analysis of cell cycle phase distribution.
In addition, future experiments should examine cellular immune responses to Mycobacterium
avium (M. avium) infection. This model would be ideal since M. avium is an intracellular
pathogen known to primarily infect and replicate in MΦ (Inderlied et al. 1993). Additionally, this
bacterial infection is usually localized in the lungs and the primary route of infection is the
respiratory tract (Horsburgh, 1991). Therefore, M. avium would provide an ideal basis to
assess the effect of carbon nanoparticle exposure on murine pulmonary MΦ function and the
ability of infected cells to clear a bacterial infection. Further understanding of the mechanisms
involved between MΦs and immune responses to carbon nanoparticles would ideally be
addressed in an in vivo mouse model study, where intranasal administration of the
nanomaterials would precede an M. avium infection thus providing the opportunity to examine
the ability of these mice to clear a lung infection in the presence of the carbon nanoparticles.
Such studies would be quite beneficial to identify other factors that would increase
understanding of nanoparticle effect in biological systems.
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GLOSSARY
OAPC – Antigen presenting cells
MΦ – Macrophages
DC - Dendritic cells
ROS – Reactive oxygen species
IFNγ – Interferon-γ
MHCII – major histocompatibility complex class 2 antigen
TNFα– tumor necrosis alpha
IL - interlukin molecules (e.g. IL-12, IL-4)
Th1 – Type 1 Helper T cells
ATP – Adenosine-5’-triphosphate
BC – Vulcan XC-72 black carbon
MWCNT – Multi-walled carbon nanotubes
CNT – Carbon nanotubes
PM – Particulate matter
TEM – Transmission electron microscopy
SAED – Selected area electron diffraction
TLR – Toll-like receptors ligands
NO – nitric oxide
CD – Cluster of differentiation (e.g. CD86, CD40)
LPS – Lipopolysaccharide
M. avium – mycobacterium avium
COPD – chronic obstructive pulmonary disease
RAW264.7 cells – murine macrophage cell line
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A549 cells - Human epithelial lung cell line
OVA-DQ - Self- quenched conjugate of ovalbumin
LC-50 – lethal concentration
DMSO – dimethyl sulfoxide
RLU – relative light units
CO2 – carbon dioxide
MEM – minimum essential medium
DMEM – Dulbecco’s Modified Eagle’s medium
FBS – fetal bovine serum
HBSS – Hanks buffered salt solution
PBS – phosphate buffered saline
MTS - 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2Htetrazolium, inner salt
SDS-HCL – sodium dodecyl sulfate in Hydrochloric Acids solution
MPER – mammalian protein extraction reagent
EDTA – ethylenediaminetetraacetic acid
Ab – antibody
SDS – sodium dodecyl sulfate
BSA – bovine serum albumin
[3H] - Thymidine
ELISA – enzyme-linked immunosorbent assay
HSP – Heat shock proteins
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APPENDIX

Figure A1. Transmission electron microscopy image of internalized BC aggregated nanoparticles inside
cytoplasmic vacuoles. MФ were treated with MWCNT or BC and were examined by TEM 7 days post
treatment. Ultra-thin sections were cut, placed on copper grids, stained with uranyl acetate and lead
citrate, and examined by TEM (80-kV)(Magnification: 20000x)

76

Figure A2. Transmission electron microscopy analysis of MΦ cells treated with MWCNT did not indicate
intracellular uptake of these nanoparticles. MФ were treated with MWCNT or BC and were examined
by TEM 7 days post treatment. Ultra-thin sections were cut, placed on copper grids, stained with
uranyl acetate and lead citrate, and examined by TEM (80-kV)(Magnification: 20000x)
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Figure A3. Transmission electron microscopy image of negative control (untreated) MΦs. MФ were
treated with MWCNT or BC, vehicle control (DMSO), and negative control (untreated) and were
examined by TEM 7 days post treatment. Ultra-thin sections were cut, placed on copper grids, stained
with uranyl acetate and lead citrate, and examined by TEM (80-kV)(Magnification: 20000x)
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Figure A4. Transmission electron microscopy image of vehicle control (DMSO) treated MΦs. MФ were
treated with MWCNT or BC, vehicle control (DMSO), and negative control (untreated) and were
examined by TEM 7 days post treatment. Ultra-thin sections were cut, placed on copper grids, stained
with uranyl acetate and lead citrate, and examined by TEM (80-kV)(Magnification: 8000x)
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Figure A5. Chronic BC “pre-exposure” or “exposure” does not alter MΦ mitochondrial membrane
potential. MФ were treated with MWCNT or BC and “pre-exposure” (A) samples were activated with
100ng/mL of LPS. MΦs were tested for mitochondrial permeability using the MitoProbe™ JC-1 Assay
Kit 7 days post-treatment and analyzed by flow-cytometry. Untreated-cells (media) and vehicletreated cells (DMSO) were used as controls. This data is presented as the mean ± SEM of duplicate
wells and is one of three representative experiments.
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Figure A6. Chronic “pre-exposure” and “exposure” to BC is cytotoxic to RAW264.7 cells. MФ were treated
with MWCNT or BC and “pre-exposure” (A) samples were activated with 100ng/mL of LPS.
Treatments were tested for cytotoxicity by LIVE/DEAD assay 7 days post-treatment. Untreated-cells
(media), vehicle-treated cells (DMSO), and camptothecin-treated cells (Camp) were used as controls
for the absence or presence of cell death. This data is presented as the mean ± SEM of quadruplicate
wells and is one of three representative experiments.
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Figure A7. Chronic “pre-exposure” and “exposure” to BC is cytotoxic to RAW264.7 cells. MФ were treated
with MWCNT or BC and “Pre-Exposure” (A) samples were activated with 100ng/mL of LPS.
Treatments were tested for cytotoxicity by trypan blue exclusion assay 7 days post-treatment.
Untreated-cells (media) and vehicle-treated cells (DMSO) were used as controls for the absence of cell
death. This data is presented as the mean ± SEM of duplicate wells and is one of three representative
experiments.
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